Common Cold

Common Cold

Last updated: 04/2021

Contributor(s): Dr. Maureen Williams, ND; Dr. Shayna Sandhaus, PhD

1 Overview

Summary and Quick Facts

  • The common cold is the most frequent acute infectious illness in the United States.
  • The common cold can be caused by more than 200 subtypes of rhinovirus, influenza viruses, and other common viruses.
  • Treatment strategies for the common cold are generally aimed at relieving symptoms and minimizing risk of complications.
  • Several nutrients such as vitamin D, zinc lozenges, beta-glucans, and probiotics may help prevent colds and manage symptom duration and intensity.

What is the Common Cold?

The common cold is a viral infection of the upper respiratory tract. Common colds can be caused by over 200 distinct viral pathogens, typically from the rhinovirus, influenza virus, and other common virus families. Because there are so many distinct cold-causing viruses, developing immunity against the common cold is unlikely.

Infection occurs when the virus reaches mucous membranes (eg, eyes, nose, mouth), often via direct contact or respiratory droplets from an infected individual. Colds generally resolve without treatment, and conventional treatments are mostly palliative and aim to shorten the duration of the illness and prevent complications such as a secondary bacterial infection. However, no cold medication is yet known to effectively decrease duration, severity, or risk of complications.

Nutrients such as probiotics, vitamin D, and zinc lozenges may help prevent the common cold and aid the body’s immune response.

What are Signs and Symptoms of the Common Cold?

  • Nasal swelling and congestion
  • Runny nose
  • Sore throat
  • Coughing and sneezing
  • Low-grade fever
  • Mild aches

Note: Cold symptoms are usually mild. If symptoms are more severe (eg, high fever, severe body aches, shortness of breath, digestive symptoms), notify a healthcare provider as this may indicate a more serious condition, such as the flu.

What are Ways to Prevent the Common Cold?

  • Wash and sanitize hands and surfaces, and avoid touching your eyes, nose, and mouth.
  • Gargling with salt water and nasal irrigation may help mechanically remove viruses from mucous membranes.
  • Maintain adequate vitamin D levels.
  • Humidify air if you are in a low-humidity environment.
  • Maintain a healthy lifestyle—avoid smoking, get enough exercise and sleep, and eat a healthy diet such as the Mediterranean diet.

What are Conventional Medical Treatments for the Common Cold?

  • DO NOT take antibiotics for a common cold.
  • Gargling (eg, with salt water) and nasal irrigation may help improve symptoms and reduce duration of the illness.
  • Some over-the-counter medications that may help relieve cold symptoms include:
    • Analgesics
    • Decongestants
    • Antihistamines, and others.

Note: Many cold medicines contain the same active ingredients. ALWAYS read labels to ensure you do not exceed the recommended dose.

What Nutrients May Be Beneficial for the Common Cold?

  • Probiotics. Specific probiotics have been shown to reduce incidence and duration of upper respiratory tract infections.
  • Beta-glucans. These prebiotic fibers may stimulate the body’s antimicrobial defense and prevent infection as well as decrease symptoms.
  • Vitamin D. Regular vitamin D supplementation and maintaining higher vitamin D levels are associated with a decreased risk of seasonal viral infection and acute respiratory infection.
  • Zinc. Zinc deficiency has been linked to immune impairment and susceptibility to infection; zinc can bolster the body’s ability to fight off viruses. Using zinc in the form of a lozenge within 24 hours of symptom onset may reduce the duration and severity of a cold.
  • Vitamin C. Vitamin C augments several aspects of the immune system and helps defend against infections. Using vitamin C may reduce the chances of catching a cold and cold duration.
  • Echinacea. Echinacea may reduce the incidence of colds and sick days, as well as reducing the risk of recurrent infections.

If you are reading this because you have developed cold symptoms, it is critical that you act quickly to halt the rapid replication of viruses occurring in your body at this very moment. Go to the nearest health food store or pharmacy and purchase:

  1. Zinc Lozenges: Completely dissolve in mouth one lozenge containing 18.75 mg of zinc acetate every two waking hours. Do not exceed eight lozenges daily, and do not use for more than three consecutive days.
  2. Garlic: Take 9,000‒18,000 mg of high-allicin garlic each day until symptoms subside. Take with food to minimize stomach irritation.
  3. Vitamin D: If you do not already maintain a blood level of 25-hydroxyvitamin D over 50 ng/mL, then take 50,000 IU vitamin D the first day and continue for three more days and slowly reduce the dose to around 5,000 IU vitamin D each day. If you already take around 5,000 IU vitamin D daily, then you probably do not need to increase your intake.
  4. Cimetidine: Take 800‒1,200 mg cimetidine daily in divided doses. Cimetidine is a heartburn drug that has potent immune-enhancing properties. (It is sold in pharmacies over-the-counter.) Note: cimetidine can interact with many drugs and potentially cause adverse effects. Talk with a qualified healthcare provider or pharmacist before starting cimetidine to be sure you do not take any drugs that could interact with cimetidine.
  5. Melatonin: Take 3 to 50 mg at bedtime.

Do not delay implementing the above regimen. Once the cold virus infects too many cells, it replicates out of control and strategies like zinc lozenges will not be effective. Treatment must be initiated as soon as symptoms manifest!

2 Introduction

The common cold is a viral infection of the upper respiratory tract that typically causes symptoms such as a runny or stuffy nose, sneezing, coughing, sore throat, and malaise. American adults contract an average of two to three colds per year and children contract as many as eight, making common cold the most frequent acute infectious illness in the United States, as well as the rest of the industrialized world.1

The common cold is generally a mild, self-limiting, and can be distinguished from more severe infections (eg, influenza) by the absence of digestive, neurological, and severe systemic symptoms. Although some people experience systemic symptoms such as fatigue, headache, fever, and muscle aches, the intensity of these symptoms is milder in those with a common cold.2

Common colds, like other respiratory viral infections, begin when viruses infect the cells lining the upper airways. Viruses reach the respiratory mucosa by being inhaled into the nose or mouth, or by direct contact, such as when contaminated hands touch the mouth, nose, or eyes. In most cases, the mucosal immune system clears the infection in a few days, causing mild symptoms in the process; however, common colds can exacerbate respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) and increase vulnerability to secondary infections that can result in rhinosinusitis, influenza, or pneumonia, particularly in smokers, young children, the elderly, those with chronic diseases, and those with weakened immune function.6,7

Stress, sleep disturbance, smoking, allergies, chronic diseases, and use of some medications are associated with more frequent or more severe colds, whereas limiting exposure to respiratory viruses through hygiene can reduce risk and prevent spread of the common cold.1,8,9 Engaging in regular moderate-intensity physical activity, getting adequate sleep, and managing stress can help maintain the immune system’s ability to mount a balanced response to respiratory viral infections, including those that cause the common cold.338-340 Eating a diet rich in vitamins, minerals, fiber, and phytonutrients supports healthy immune function and may lower the risk of infection.13-15

Conventional therapies for the common cold, such as analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), decongestants, and antihistamines, as well as saline nasal irrigation, provide varying degrees of symptom relief but do not shorten the course of the illness.16 Nasal irrigation and gargling with salt water may reduce viral load and thereby shorten respiratory viral infections, decrease symptom severity, and limit transmission. In addition, a growing body of evidence supports the use of integrative therapies such as probiotics, vitamin D, zinc lozenges, and vitamin C, as well as treatment with medicinal herbs like echinacea, andrographis, and ginseng, for reducing the severity and duration of colds.9,18,19 Importantly, antibiotics, which are only effective against bacterial infections, are not indicated for the common cold.16,20

3 Background

More than 200 subtypes of viruses are known to cause of the common cold, and new cold-causing viruses are still being identified.1,9 Viruses in the rhinovirus family are the most frequent cause, responsible for an estimated 30–50% of colds. Influenza viruses may cause another 5–15%.1 Viruses in these families can also cause other types of illnesses: for example, rhinoviruses can cause ear infections, sinus infections, and pneumonia,21,22 and influenza viruses typically cause flu-like illnesses and are also responsible for some pneumonias.23

4 Risk Factors

The common cold has long been noted to be more prevalent in winter months in temperate regions. This is due to climate-related changes in viral stability and transmission properties, the immune response, and human behavior (for example, spending more time indoors).30

In addition to seasonality, several other factors increase the likelihood of contracting a cold1,8:

  • lose contact with children, such as in schools and daycare settings
  • Asthma and allergic rhinitis (nasal swelling)
  • Smoking
  • Stress
  • Sleep disorders
  • Chronic illness
  • Medications that suppress immune function, such as prednisone, dexamethasone (Decadron), azathioprine (Imuran), and cyclosporine (Gengraf).

Immune Senescence and Common Cold

The immune system undergoes marked age-related remodeling, known as immune senescence, that gradually weakens the response to infections and leaves the elderly more vulnerable to both acute infections and chronic inflammatory conditions.32 With increasing age, the relative populations of various immune cell types change. For example, immune cells involved in immunological memory and recognition of previously encountered pathogens are typically over-represented and those involved in responsiveness to new antigens are under-represented. Overall, numbers of exhausted and dysfunctional immune cells grow and expression of inflammation-related genes increases. In this immunosenescent landscape, the response to viral infections like the common cold are less effective at clearing the infection and more likely to result in dysregulated inflammation.32,33 Immune senescence is thought to be a major contributing factor to high rates of viral respiratory outbreaks and increased hazards of complications, such as secondary bacterial infections, in long-term care facilities.34

Exercise, eating a healthy diet, and maintaining a healthy body weight can help limit or slow immune senescence. In older individuals, both aerobic and resistance exercise have been found to balance anti-inflammatory and pro-inflammatory immune signaling molecules and improve immune regulation.35,36 Healthy eating habits such as those comprising the Mediterranean-like and DASH (Dietary Approaches to Stop Hypertension) diets have been linked to markers of immune responsiveness and reduced inflammation.37,38 Calorie restriction, the practice of regularly consuming fewer calories without causing nutrient deficiencies, has been widely shown to have positive effects on immune function in many animal models of aging, and promising health effects have been reported from controlled trials in humans.39-42 In addition, some evidence suggests integrative therapies such as melatonin,43 cistanche,44 Pu-erh tea,45 and reishi46 may be able to slow or reverse some effects of aging on immune function.

More information is available in Life Extension’s Immune Senescence protocol.

5 Symptoms

Usual symptoms of the common cold include1,8:

  • Nasal swelling and congestion
  • Runny nose
  • Sore throat
  • Cough
  • Headache
  • Low-grade fever
  • Muscle aches
  • Malaise (general feeling of being unwell)

Notably, these symptoms are mild in individuals with a cold. The presence of digestive symptoms or severe and body-wide symptoms, such as fatigue, fever, body aches, shortness of breath, and malaise, may indicate a more serious infection such as influenza.2,33,4

Table 1: Comparison of Characteristics: Common Cold and Influenza1-4,8
Common Cold
Causative virus(es)
influenza viruses,
and others
influenza A virus
influenza B virus
influenza C virus
Site of infection
Upper respiratory tract
Upper and lower respiratory tracts
Incubation period
1–3 days
1–4 days
Onset of illness
Duration of illness
Typically 7–10 days
Typically 7–14 days
Severity of illness
Mild to severe
Nasal congestion and runny nose
Sore throat
Characteristic, usually mild to moderate
Characteristic, can be severe
Common, usually mild
Rare, low-grade
Characteristic, can be high
Muscle aches
Uncommon, usually mild
Characteristic, often severe
Common, usually mild
Characteristic, often severe
Shortness of breath
Diarrhea and/or vomiting
Loss of sense of smell (without nasal congestion) or taste
Other neurological symptoms

6 The Course of the Common Cold

Common cold-causing viruses can be contracted in at least three ways1,23:

  • Direct contact. Hands are an important route of transmission for common cold-related viruses. When an uninfected person touches an infected person who is actively shedding viruses, or touches surfaces contaminated with shed viruses, they can then transmit the virus to their own respiratory tract by touching their eyes, nose, or mouth.
  • Respiratory droplet. Respiratory droplets emitted during coughing or sneezing can harbor cold-causing viruses, carrying them short distances. These infectious droplets contribute to cold transmission when inhaled by those in close proximity or land on surfaces and are picked up by hands.
  • Aerosol. Some exhaled viruses can become suspended in tiny droplets of moisture that linger in the air for long periods of time. Aerosolized viruses can be spread by natural or mechanically induced air currents and thereby infect people farther away from the source.

Although direct contact and respiratory droplet are accepted as major routes of cold virus transmission, the role of aerosol in spreading the common cold has not been well defined and is likely to vary between types of cold-causing viruses.1,5 One study in people with respiratory infection due to influenza virus found people with lung (ie, lower respiratory) infections emitted infectious viruses in aerosols during coughing, sneezing, and normal breathing; however, upper respiratory infections were not strong predictors of infectious aerosol emission.48 Aerosolized rhinoviruses have also been detected, but whether this is an important mechanism of spread for the common cold is still unclear.49

Infection and Incubation

Cold-causing viruses attach and gain entry to upper respiratory epithelial cells (cells that line the respiratory tract) by interacting with molecules on epithelial cell surfaces.21 Once inside a cell, the virus releases its genetic material and triggers conversion of cellular activity to support production of viral proteins and viral replication. Newly generated viruses are released into the airway where they can infect nearby cells or be shed through breathing, sneezing, and coughing.

The time from infection to symptom onset is known as the incubation period. The incubation period in cases of the common cold can be as short as 10–12 hours but is usually between one and three days. During this time, the infected person is shedding transmissible virus unknowingly. Once symptoms begin, they typically last between three and 10 days; however, symptoms persist for as long as two weeks in about 25% of individuals, especially smokers and those with weakened immune function. The rate of viral shedding generally coincides with symptom severity, peaking on day two or three of illness, then persisting at a low level for a week or longer, especially in children.1

Illness and Recovery

Viral infection triggers the release of a wide array of pro-inflammatory molecules, which are responsible for the well-known symptoms of the common cold.8,51 Interferons and cytokines produced by infected cells help inhibit infection spread to nearby cells and initiate the immune response. Leukotrienes, bradykinin, and other peptides released as part of the immune response stimulate mucus secretion, vasodilation, and increased blood vessel permeability that lead to nasal congestion and runny nose. In addition, some of these molecules trigger increased acetylcholine signaling in the nervous system, which can further contribute to mucous production, coughing, and sneezing.8,51 Both viral activity and the immune response cause varying degrees of cell damage and disruption to the integrity of the epithelial barrier, leading to increased risk of secondary infections.22,51

Ultimately, the immune response leads to containment of infection, destruction of infected cells, tissue repair, and restoration of homeostasis. In addition, specialized immune cells develop lasting memory that may prevent re-infection by the same virus. Nevertheless, since there are many cold-causing viruses with vast variability in the specific immune response they elicit, recovery from the common cold does not protect against another cold, and many people experience multiple colds in one season.1,22


For most people, the common cold is a mild and self-limiting illness, but occasionally it progresses to, or exacerbates, a more serious condition. This is more likely in6,52:

  • Smokers
  • Pregnant women
  • Children under 2 years old
  • Adults over 60 years old
  • Those with asthma, COPD, or other lung conditions
  • Those with other chronic diseases, such as heart disease, kidney disease, diabetes, or cancer
  • Those whose immune systems are compromised due to a health problem or its treatment

Complications arise when cold-causing viruses infect other regions of the respiratory tract, such as the sinuses (sinusitis), middle ear (otitis media), large bronchial tubes (bronchitis), or lungs (pneumonia). Secondary bacterial infections, which are often more serious, can also affect the sinuses, throat, bronchial tubes, and lungs.1,6 Furthermore, the common cold is a frequent trigger of asthma and COPD exacerbations.6,53

Some people experience a lingering cough at the tail end of a common cold, even after other symptoms have long resolved. This post-viral cough, which occurs with no lung involvement, lasts between three and eight weeks. If it persists longer than eight weeks, it is considered a chronic cough. Although the mechanism underlying post-viral cough is not fully understood, hyper-sensitization of the cough reflex by bradykinin and other inflammatory mediators or due to damage to the epithelial barrier is thought to play a major role.6,51

Another possible sequela of the common cold is post-viral acute rhinosinusitis (inflammation of the nasal passages and sinuses). While rhinosinusitis is one of the most frequent features of the common cold, it is considered post-viral if it persists longer than 10 days or worsens after the fifth day of a cold. Its cause appears to be inflammatory in nature, rather than infectious. The risk of secondary bacterial rhinosinusitis is higher in those with post-viral rhinosinusitis.16

7 Diagnosis

The most important aspect of diagnosing a common cold is ruling out other conditions that could be more serious or treatable.54 In general, the presence of characteristic symptoms and absence of indicators of more serious illness are sufficient for diagnosis.1,8 Physical exam findings such as nasal mucosal swelling, throat redness, and possibly low-grade fever, along with normal lung sounds, can help secure an uncertain diagnosis.1

Other serious infections, in their milder manifestations, can also be confused with the common cold. These include influenza and pertussis (whooping cough).1 A more severe cough, involvement of the lungs, and systemic symptoms like muscle ache, fever, and malaise indicate possible influenza,2 and a persistent cough that comes in fits that sometimes induce vomiting and exhaustion, as well as a whooping sound when breathing in, points to pertussis.56 Finally, allergic rhinitis (respiratory allergies or hay fever) often mimics a common cold with runny nose and nasal congestion but is more frequently marked by itching of the nasal mucosa or eyes.54,57

The following conditions frequently overlap or share symptoms with the common cold, and a small percentage of cases are due to bacterial infections that may respond to antibiotic therapy:

  • Acute rhinosinusitis. Swelling of the nasal passages and sinuses, or rhinosinusitis, can occur during or following the common cold. In addition to nasal congestion and discharge, it may be marked by facial pain. Acute rhinosinusitis can be caused by a bacterial infection, but most cases are viral.6
  • Acute pharyngitis. A sore throat is a characteristic symptom of the common cold, but when it is the predominant symptom, it may indicate simple acute pharyngitis. It is estimated that 70–95% of pharyngitis cases are viral, while the rest are bacterial (eg, strep throat).6
  • Acute bronchitis. Bronchitis is an inflammation of the trachea and large bronchial passages, but it does not involve the lungs. Acute bronchitis frequently follows a cold and is characterized by a cough that may be accompanied by chest pain, wheezing, shortness of breath, and breath sounds known as crackles or rales that can be heard during a physical exam.6,58 Although most cases are viral, acute bronchitis can be caused by bacterial infection.58

In the vast majority of cases, lab tests are not needed to diagnose the common cold.54 In rare instances, a procalcitonin level may be useful in confirming the absence of a bacterial infection.1 Procalcitonin levels have been shown to be elevated in bacterial, but not viral, infections. Monitoring procalcitonin has been proposed as a strategy for distinguishing bacterial from viral respiratory illnesses and guiding decisions around antibiotic prescription.59,60 For example, a low procalcitonin level may help secure the diagnosis of common cold and avoid unnecessary antibiotic therapy by ruling out suspected bacterial rhinosinusitis.61

8 Prevention

Handwashing and Hand Sanitizing

Frequent handwashing is recommended as an important strategy for reducing the spread of cold viruses, as well as pathogenic bacteria.9,23,62 Cold-causing viruses have been found to remain viable on skin for as long as two hours.1 Thorough hand washing can effectively remove viruses, bacteria, fungi, and microbe-harboring soil from hands, thereby preventing self-inoculation via touching the eyes, nose, or mouth, and transmission to others via direct contact or contamination of touched surfaces. Frequent cleaning of high-touch surfaces like doorknobs and faucets may also reduce viral spread.64 Respiratory viruses generally remain viable longer on hard surfaces like metal and plastic than on soft, porous surfaces like cloth, paper, and cardboard.65,66

Alcohol-based hand sanitizers may play a role in cold prevention since they can be used in circumstances where hand washing is not possible. The virus-killing action of alcohol, especially ethanol, is effective against several major cold-causing viruses. Rhinoviruses are relatively resistant to alcohol-based hand sanitizers and surface disinfectants22; nevertheless, the use of an alcohol-based hand sanitizer, along with routine hand washing, has been found to reduce the presence of rhinovirus on hands more than hand washing alone.68 Hand sanitizers with alcohol concentrations of 60–95% are more likely to be effective against an array of viruses than those with lower concentrations.

Gargling and Nasal Irrigation

Gargling and nasal irrigation are practices that may mechanically reduce the presence of cold-causing viruses on the upper respiratory mucosa. In a clinical trial that included 387 adults, gargling with tap water three times daily for 60 days during winter was found to lower the incidence of upper respiratory tract infections and was more effective than gargling with iodine.69 A trial in children aged 2–6 years found gargling with water or green tea reduced the likelihood of fever, a common symptom of upper respiratory infection in this age group.70 Some research also suggests gargling with green tea may reduce the risk of influenza.71

Maintaining Adequate Vitamin D Levels

Maintaining adequate vitamin D levels may help prevent viral respiratory infections such as the common cold. Vitamin D deficiency has been correlated with increased incidence of colds and flu in multiple studies.72,73 In a study that took place in Connecticut, 198 healthy adults were monitored through the winter months; those who maintained vitamin D levels ≥38 ng/mL had 2.7 times lower incidence of acute respiratory illnesses and 4.9 times fewer sick days than those whose vitamin D levels were <38 ng/mL.74


Ambient air temperature and relative humidity are factors that affect the viability of airborne viruses and function of cells lining the nasal passages. Cooler and drier air conditions may influence the spread of viral respiratory infections both by increasing survival of aerosolized viruses and impairing the ability of the respiratory mucosa to clear pathogens.75-78 Fluctuating climatic conditions may also be important in determining risk of infections: In a study that included 892 participants in Antarctica, a 3-day period in which both temperature and humidity dropped was found to be correlated with increased incidence of upper respiratory infections caused by rhinoviruses.79 A study that evaluated the infectivity of influenza viral particles using simulated coughing in various relative humidities found humidity levels above 40% were associated with reduced infectivity. In this study, viral particles collected 60 minutes after simulated coughing retained about 70–77% infectivity in relative humidity at or below 23%, but retained only 15–22% infectivity at relative humidity at or above 43%.80 Observational studies have noted decreased risk of respiratory infections in individuals working or living in environments with relative humidities in the mid-range of 40–60%, versus lower and higher relative humidities.81

Based on the evidence described in the preceding paragraph, using a humidifier in low-humidity climates may help reduce the risk of respiratory viral infections. Portable humidifiers have been reported to raise room air humidity by 15–20%, and could lower survival of airborne influenza viruses by an estimated 17.5–31.6%.82

9 Treatment

Gargling and nasal irrigation may be helpful as a treatment for common colds.83 An open-label randomized controlled trial with 61 participants found saline nasal irrigation plus gargling, beginning within 48 hours of the onset of cold symptoms, reduced the duration of illness by almost two days, over-the-counter medication use by 36%, and transmission to others in the household by 35%. Nasal swabs indicated those using nasal irrigation and gargling had decreased viral shedding.84 In children under 2 years of age with the common cold, the use of saline or seawater nasal drops relieved nasal congestion and improved sleep, nutrition, and strength compared with no nasal drops.85

Many people use steam inhalations in the hope of thinning nasal secretions and relieving cold symptoms19; however, the evidence is mixed. Two clinical trials found nasal delivery of heated humidified air (steam) shortly after symptom onset did not reduce cold symptoms during seven days of monitoring compared with similar delivery of non-humidified room-temperature air,86,87 while another controlled trial found two 30-minute treatments with steam one week apart reduced nasal swelling and improved openness of nasal passages compared with placebo treatment.88 In addition, a controlled trial found 30-minute steams performed once on the first day and again on the second day after experimental inoculation with a common cold-causing virus had no impact on viral shedding after five days.89

There are no medications known to effectively decrease duration, severity, or risk of complications from the common cold. Individuals with moderate-to-severe symptoms may benefit from therapies aimed at symptom reduction, but potential adverse side effects also need to be considered.9,20 In particular, cold medications should not be used in children under four years of age, in whom the potential harms outweigh the possible benefits.19 Antibiotics should not be used to treat uncomplicated common colds, but reserved for cases of secondary bacterial infections.20,23

Table 2: Symptomatic Therapies for the Common Cold
Medication Type Target Symptoms Comments
(non-steroidal anti-inflammatory drugs [NSAIDs]) and
acetaminophen (Tylenol)
Muscle pain
Other types of pain

While they may relieve certain symptoms, these medications have been found not to reduce duration or overall symptom score in those with common colds.90

(pseudoephedrine and phenylephrine)
Nasal congestion
Nasal swelling
Pseudoephedrine may have a small benefit on nasal symptoms, but its sale is restricted in the United States; phenylephrine is less effective and may not be better than placebo.20
(diphenhydramine [Benadryl])
Nasal swelling
Runny nose
There is a small likelihood of symptom reduction in the first few days of a cold, but the possible benefit must be weighed against common side effects such as sedation and dry eyes, nose, and mouth.20,91 Combinations containing an antihistamine and a decongestant, with or without an analgesic, have more evidence indicating benefit.92
(dextromethorphan, codeine)
Cough Evidence supporting dextromethorphan is mixed and benefit, if any, is small93; codeine, an opiate that is not safe in children, has not demonstrated effectiveness in cases of uncomplicated common cold.19,54
Cough Evidence for guaifenesin’s effect on cough associated with the common cold is mixed.19,94

Anti-asthma Medications
(ipratropium [Atrovent] and cromolyn)
Runny nose
Nasal congestion
Inhaled ipratropium (an anti-cholinergic) reduces cough and may lead to improvement in those with acute asthma exacerbation.19,95,96
One clinical trial found cromolyn (a mast cell stabilizer), whether inhaled or used as a nasal spray, reduced upper respiratory tract symptoms, especially cough.97 Limited evidence suggests cromolyn use by allergy and asthma patients may reduce common cold risk.98,99

Cimetidine and the Common Cold

Cimetidine (Tagamet) is an over-the-counter drug that reduces gastric acid secretion by inhibiting a type of histamine receptor (H2 receptors) found in the gastric lining. It is mainly used to treat gastroesophageal reflux disorder (GERD), but is sometimes used to treat gastric and duodenal ulcers and viral warts.100 Histamine H2 receptors are also found on all types of immune cells, and cimetidine has been shown to modulate immune cell activity. Preclinical studies indicate cimetidine activates monocytes, neutrophils, and other non-specific immune cells, yet inhibits generation of free radicals by neutrophils. This reduces potential tissue damage and uncontrolled inflammation. Cimetidine has also demonstrated the capacity to upregulate natural killer (NK) cells, as well as T and B cells that interact with pathogens via recognition of specific proteins by immune receptors and antibodies.101 Furthermore, cimetidine increases signaling by antiviral cytokines, including interferons, and decreases signaling by immunosuppressive cytokines.101,102

Note: Cimetidine affects the metabolism and clearance of a number of other medications and should be used with caution by those taking drugs for other conditions. For example, cimetidine should not be used by those taking the antiviral drug delavirdine (Rescriptor), bone-building drug risedronate (Actonel), broad-spectrum antibiotics cefuroxime (Zinacef) and cefditoren (Spectracef), or triple therapy for Helicobacter pylori infection that includes bismuth, metronidazole (Flagyl), and tetracycline (Sumycin).104

10 Novel and Emerging Therapies

The development of a vaccine to prevent and treat the common cold is hampered by the existence of a myriad of causative viruses and their rapidly mutating nature.105 The search for effective treatment faces these same challenges, as well as the likelihood that antiviral agents may only be effective if initiated around the time of peak viral replication, which may be before or at the onset of symptoms.9 Furthermore, because the common cold is generally mild and self-limiting, there is the possibility that vaccine- or medication-related adverse side effects could be worse than the cold itself.

Capsid-binding agents block the uncoating of viruses and prevent their entry into cells. Capsid-binding drugs such as pleconaril have shown particular promise against respiratory viruses in preclinical research, and researchers are currently seeking antiviral drugs with a similar mode of action as potential treatments for respiratory viral infections.107-109 In an analysis of results from two randomized placebo-controlled trials that included a combined total of 2,096 patients with the common cold, pleconaril, administered within 24 hours of symptom onset, was found to have shortened the duration of illness by an average of 2.3 days in subjects infected by specific susceptible rhinovirus strains, but did not alter the course of infection in those with non-susceptible viruses. The researchers estimated approximately half of participants were infected with susceptible viruses.110 Pleconaril was associated with slightly increased risk of mild-to-moderate adverse side effects, including headache, nausea, and diarrhea, in common cold patients.111 Pleconaril is not approved for systemic use in the United States as of early 2021, but is used on a compassionate basis of some conditions in infants.112 It is hoped that new antiviral drugs with broader efficacy will be identified.108

11 Dietary and Lifestyle Interventions


One of the most important lifestyle factors influencing risk and severity of the common cold is smoking. Cigarette smoke and nicotine from electronic cigarettes alter the mechanical function of the respiratory lining and dull the cough reflex, making it more difficult to clear pathogens. Smoking and vaping also cause toxic damage to the airway epithelium, disrupt immune activity, and trigger heightened inflammation, further increasing susceptibility to infection.7,113-115 Although less is known about vaping, researchers have found cigarette smokers are approximately twice as likely to experience the common cold as non-smokers and have higher rates of complications like pneumonia.7 Exposure to secondhand smoke also increases common cold risk: in one study, those with regular secondhand smoke exposure had an almost 60% higher likelihood of becoming sick with a cold.7,116 A number of studies suggest smoking is correlated with increased rates of complications of respiratory infections as well.7


Regular moderate-intensity physical activity is associated with reduced inflammation and stronger antiviral immune activity, while the extremes of physical inactivity and overtraining can weaken immune defenses and raise inflammatory signaling.10,118 Some evidence suggests exercise may limit or delay the effects of aging on immune function and help restore competent immune responsiveness in older individuals.119 A review of observational and randomized controlled trials noted engaging in moderate aerobic exercise daily or almost daily lowers the risk of upper respiratory infections like the common cold by approximately 40–50%, and is also associated with shorter upper respiratory illnesses.118 One controlled trial included 115 overweight or obese, sedentary, postmenopausal women who were randomly assigned to an exercise group (45 minutes of moderate intensity exercise five days per week) or a stretching group (45 minutes of stretching once per week) for one year. In the final three months of the trial, the incidence of colds was three times higher in the stretching versus the exercise group.120


Sleep is vital for healthy immune function, and impaired sleep can disrupt the balance between inflammatory and anti-infection immune activity. Even one night of partial sleep deprivation has been shown to suppress an important aspect of normal immune function for more than four days.121 In a study that included cold histories from 651 military recruits undergoing basic military training, those who routinely slept less than six hours per night were four times as likely to be diagnosed with an upper respiratory infection than those who slept seven to nine hours per night.122 This evidence was supported by a clinical trial in which 164 healthy adults wore devices to assess their sleep duration and continuity for seven days, and were then experimentally exposed to a cold-causing rhinovirus. Those who slept six hours or less per night had a more than four-fold higher risk of developing a cold.123 In a similar study that included 153 healthy adults between age 21 and 55 years old, the odds of developing a cold after rhinovirus exposure were almost three times higher in those who reported sleeping less than seven hours per night compared with those who reported sleeping eight hours or more. Sleep efficiency (percentage of time in bed spent sleeping) is also a factor in the ability to defend against cold viruses. Even among those with good sleep efficiency, decreasing time awake during the night may add to protection: the study described above also noted a 5.5-fold lower risk of a cold in those reporting the highest sleep efficiency (98% or higher) compared with those reporting the lowest sleep efficiency (less than 92%).124

Stress Management and Social Support

Chronic psychological stress has been found to increase the risk of upper respiratory tract infections, while social support reduces the risk.12 One study evaluated stress based on recent stressful life events (eg, death of a spouse or job loss), perceived stress level, and emotional state (eg, anxiety or depression) in 394 healthy volunteers before exposing them to cold-causing viruses and found those with higher stress scores were more likely to develop colds than those with lower scores.125 The same researchers noted persistent interpersonal problems and being under- or unemployed were stressors most closely correlated with a higher chance of developing a cold after virus exposure.126 On the other hand, they found having larger and more diverse social networks was associated with lower susceptibility to the common cold.127

More recent studies have noted better mental health and lower psychosocial stress levels are associated with lower incidence of acute respiratory infection.128,129 One study examined participants’ use of an emotional regulating skill called cognitive reappraisal, which is re-interpreting emotional situations in ways that change their emotional impact. The study found those who reported more frequent use of cognitive reappraisal strategies had lower nasal production of inflammatory cytokines and less severe cold symptoms after experimental exposure to rhinovirus.130 In another study, 154 participants were assigned to an eight-week mindfulness training group, eight-week exercise training group, or control group and were monitored for common colds during the cold and flu season. The mindfulness group had significantly reduced cold severity and fewer missed days of work compared with the control group. In addition, the mindfulness and exercise groups had fewer colds and shorter cold duration than the control group, but these differences did not reach statistical significance.131


A healthy diet that supplies adequate amounts of vitamins A, B complex, C, D, and E, as well as zinc, selenium, magnesium, iron, copper, and omega-3 fatty acids supports normal immune function and defense against respiratory viral infections like the common cold.13,132 In an open clinical trial, 128 children with recurring colds and frequent inflammatory complications whose families adopted a traditional Mediterranean diet, a well-established health-promoting dietary pattern, had reduced frequency of infection and medication use at the end of one year.133 In women, higher intake of fruits and vegetables, as sources of vitamin C, has been associated with lower risk of respiratory infection.134,135 Kiwifruit in particular has been shown to protect against common colds: a randomized cross-over trial in 32 elderly adults found eating four kiwifruits per day for four weeks reduced the severity and duration of common cold symptoms.136

In addition to vitamin C, fruits, vegetables, and other plant foods provide fiber, polyphenols, carotenoids, and other phytochemicals and nutrients that support balanced immune activity and may have direct antiviral effects.14,15 Although whole foods are likely to be more beneficial, one randomized placebo-controlled trial found participants who supplemented with encapsulated fruit and vegetable extracts for eight months had 20% fewer days with moderate-to-severe cold symptoms compared with placebo.137 Plant-based nitrates, such as those found in beet roots, may also protect against colds by increasing availability of nitric oxide, which is important for healthy epithelial immune function. In one controlled trial, the addition of daily beet juice for seven days reduced the risk of upper respiratory infections in college students during and after final exams, and students with asthma experienced the greatest benefit.138 The inclusion of foods high in probiotic bacteria, such as kimchi and yogurt, may also lower the incidence of common colds.141

The Gut Microbiome and the Common Cold

The gut microbiome—the community of microorganisms that inhabit the intestines—plays an essential role in immune regulation. Interactions between gut microbes and gut-associated immune tissue promote the development and maintenance of a well-modulated immune system. In addition, gut microbes help reduce infection and illness by preventing colonization by pathogens, strengthening the intestinal epithelial barrier, and producing anti-inflammatory compounds through fermentation of dietary fibers.143

Dysbiosis—an imbalance in the composition of the gut microbiome—can disrupt intestinal barrier function and lead to an inflammatory state, and may reduce immune defenses against viruses, including those that cause the common cold.143 Psychological stress, sleep disturbance and circadian rhythm disruption, chronic diseases, and a number of other stressors may have detrimental effects on microbiome health and are also associated with increased risk of common colds.1,145 Acute viral respiratory infections can also disturb the microbial balance of the airways and gut thereby increasing vulnerability to secondary infections.143 A diet rich in fermentable fiber and supplemental probiotics can help restore a healthy gut microbiome, improving immune function, and possibly lowering the risk of viral upper respiratory infections.146

The upper respiratory tract also has a substantial and diverse microbiome. Studies indicate microbial residents of the upper respiratory tract influence respiratory immune function and infection susceptibility, although less is known about this microbial community than the gut microbiome.143,148,149


Chronic heavy use of alcohol has been linked to impaired immune function and increased risk of infectious illnesses and complications. The effect of regular moderate alcohol use, on the other hand, may enhance immunity and lower infection risk.150 A study that looked at the relationship between alcohol consumption and common cold incidence among 899 men in Japan found higher frequency of alcohol intake (but not amount) was associated with lower odds of having had common colds in the previous year.151 Another study found only wine consumption was associated with reduced risk of common cold, and the association was stronger for red wine.152

While this evidence adds common cold to the list of conditions that may be positively impacted by light-to-moderate use of alcohol, especially red wine, there is no compelling evidence to suggest non-drinkers should start drinking alcohol solely for its health benefits.155 It is important to bear in mind alcohol use, in some cases, leads to excessive use and addiction, which are harmful to health.155

12 Nutrients


Probiotics can modulate the composition of the gut microbial community and have been shown in multiple studies to improve immune defenses while reducing inflammatory activity. A meta-analysis of 12 randomized controlled trials with a total of 3,720 participants from various age groups found taking probiotic supplements reduced the number and duration of upper respiratory tract infections, resulting in decreased antibiotic use and fewer cold-related missed school days.146 Another meta-analysis that included data from 11 randomized controlled trials with a total of 2,417 children found probiotic use decreased the risk of both upper and lower respiratory infections.158

Synbiotics, which contain both probiotic organisms and prebiotic fibers that enhance the growth of beneficial bacteria in the intestines, have also been shown to lower respiratory infection risk: a meta-analysis that included findings from 16 randomized controlled trials with a combined total of more than 10,000 participants found supplementing with synbiotics reduced the incidence of respiratory tract infections by 16%.159 A series of three trials with a combined total of 721 healthy participants compared the effects of four synbiotic preparations made with mixed strains of Lactobacillus plantarum (LP 01 and LP 02),L. rhamnosus (LR 04 and LR 05), and Bifidobacterium lactis (BL 01), along with a prebiotic (either fructooligosaccharides or galactooligosaccharides), to placebo during three flu seasons. All of the preparations were found to reduce the incidence, severity, and duration of flu-like illnesses, as well as upper respiratory infections generally.160

In a placebo-controlled trial in 98 elderly subjects living in nursing homes, taking a supplement providing 3 billion colony forming units (CFUs) per day of L. coryniformis for two weeks reduced respiratory infection symptoms and influenza-like illness during five months of monitoring.161 A similar trial in 196 nursing home residents found 20 billion CFUs L. rhamnosus daily for six months reduced the risk of viral respiratory infections.162 In 205 healthy volunteers aged 45 years and older, taking 10.8 billion CFUs L. paracasei in a yogurt for 12 weeks reduced the risk of upper respiratory tract infection by 45% compared with placebo.140

In a randomized controlled trial, 152 healthy adults received either B. animalis or placebo for 28 days prior to being experimentally exposed to rhinovirus; those given the probiotic had less viral shedding in their nasal secretions during the five days following exposure.163 In a trial that included 136 participants with a history of frequent episodes of common cold and influenza-like illnesses, taking a daily supplement containing at least 63 million CFUs L. paracasei, L. casei, and L. fermentium led to greater reduction in upper respiratory tract infection frequency and enhanced antiviral immune activity compared with placebo.164 In a 12-week trial that included 96 middle-aged male office workers, 22.4% of those taking 100 billion CFUs L. casei in a fermented milk product had an upper respiratory infection versus 53.2% of those receiving a probiotic-free milk product. In addition, the duration of infection episodes was shorter in the probiotic-treated group.165 Another trial compared the effect of 12 weeks of supplementation with L. plantarum, at a dose of 1 billion CFUs per day, to placebo in 109 adults. Those taking the probiotic had reduced frequency of upper respiratory tract infections and duration of nasal symptoms. Furthermore, they showed signs of improved immune regulation, with lower markers of inflammation and oxidative stress.166


Beta-glucans, found in foods such as whole grains and mushrooms, as well as yeasts and algae, are a common type of prebiotic fiber, indigestible by human enzymes but fermentable via the digestive action of beneficial gut bacteria.167,168 Beta-glucans have been found to stimulate antimicrobial defenses through direct actions on intestinal immune tissue and modulate the inflammatory immune response through their ability to improve the health of the gut microbiome.167,169,170

In a placebo-controlled trial in 357 marathon runners, those given a yeast extract supplement providing 250 mg beta-glucan daily had fewer days with upper respiratory symptoms, lower symptom severity, and fewer missed workout days after the marathon than those given placebo.171 The same supplement was found to reduce upper respiratory symptoms and improve mood in a 12-week placebo-controlled trial in 77 women with moderate psychological stress.172 In a randomized controlled trial in 34 healthy endurance athletes, those who received 367 mg beta-glucan from algae (beta-1,3-glucan) per day for 90 days had fewer and milder upper respiratory symptoms, fewer upper respiratory infection episodes, and fewer sick days than those receiving placebo.173 In a 16-week placebo-controlled trial with 299 participants who experienced three or more upper respiratory infections in the previous year, 900 mg beta-glucan (extracted from yeast [beta-1,3-1,6-glucan]) daily reduced severity of upper respiratory infection symptoms.174 A similar trial with 162 participants found 900 mg of the same beta-glucan supplement per day reduced the incidence of upper respiratory infections by 25% and symptom severity scores by 15%.175

In 175 children with recurrent respiratory infections, those given supplements containing beta-glucan extracted from mushrooms (dosed according to body weight) had fewer flu-like illnesses and respiratory infections than those given placebo.176 Similarly, in a study of 52 healthy adults, ingestion of 5 or 10 g of shiitake mushrooms per day for 4 weeks resulted in increased levels of immune cells with the ability to proliferate. Additionally, levels of secretory immunoglobulin A in the saliva were increased, which implies improved gut immunity. The authors of this study attributed the beneficial effects of the mushrooms to compounds found in shiitake mushrooms, including beta-glucans and other compounds (eg, ergothioneine, linoleic acid).177

Vitamin D

Vitamin D modulates the immune response via receptors on various types of immune cells, supporting antimicrobial immune defenses while limiting inflammatory signaling and promoting tolerance.72,178 Vitamin D deficiency has been associated with higher incidence, increased severity, and longer duration of respiratory tract infections in children and adults.72,73 Vitamin D deficiency is common in those with chronic pulmonary disease, and restoration of vitamin D sufficiency may help prevent exacerbations, such as those caused by common colds, in people with asthma and COPD.179 Because vitamin D levels decline and the risk of respiratory infection and complications rise with age, supplementing with vitamin D may also be especially important in the elderly.180

Clinical research evaluating the effect of vitamin D supplementation has resulted in mixed findings. Inconsistencies in dosing strategies and differences in selecting participants may be factors hampering a clear understanding of the potential benefits of vitamin D.18 One clinical trial screened 428 middle-aged and elderly participants and identified 252 with insufficient or deficient vitamin D levels (≤75 nmol/L or 30 ng/mL) who were then randomized to receive 400 IU vitamin D daily or placebo for 16 weeks overlapping with cold and flu season. Those receiving vitamin D had shorter duration and decreased severity of upper respiratory tract infections, and were less likely to develop new colds during weeks 9–12.181 An analysis of data from 124 adults with compromised immune function and a history of frequent respiratory infections who participated in a vitamin D trial found those given 4,000 IU vitamin D daily had a 36% reduced risk of respiratory infections compared with placebo during one year of monitoring.182 In a placebo-controlled trial with 1,300 participants, supplementing with 14,000 IU vitamin D weekly for eight months lowered incidence of viral respiratory infections in children and adolescents by 19%.183

A meta-analysis of findings from 25 randomized controlled trials found daily or weekly vitamin D supplementation reduced the risk of acute respiratory infections, and the effect was stronger in those with low baseline vitamin D levels. Daily doses between 800 and 2,000 IU appeared to be most effective. The analysis further showed treatment regimens that included large boluses (30,000 IU vitamin D or more) did not reduce infection risk.184 Nevertheless, a controlled trial in nursing home residents found monthly 100,000 IU boluses of vitamin D, in addition to standard daily doses of 400–1,000 IU, resulted in greater respiratory infection prevention than standard daily dosing alone, but was associated with a higher risk of falling (a known adverse side effect of high-dose vitamin D supplementation).185


Zinc has an important role in stimulating the antiviral immune response, and zinc deficiency is marked by compromised immune function and increased vulnerability to viral and other infections.186

An analysis of pooled findings from six controlled trials found treatment of colds with zinc lozenges can reduce the duration of symptoms by about 2.25 days.187 A meta-analysis of three randomized controlled trials, in which a total of 199 common cold patients were given 80–92 mg elemental zinc (in the form of zinc acetate lozenges) daily or placebo, beginning within 24 hours of symptom onset, found zinc treatment reduced the duration of illness: by day five, 70% of those receiving zinc had recovered versus 27% of those receiving placebo.188 Another meta-analysis included 16 controlled trials with a total of 1,387 participants and found zinc treatment for common colds reduced symptom duration: after seven days, those receiving zinc were 55% less likely to have remaining symptoms than those receiving placebo.189

Zinc lozenges can cause adverse side effects such as a bad taste in the mouth and nausea.189 Two placebo-controlled trials have found a zinc nasal gel was also effective for shortening the duration of cold symptoms190,191; however, a zinc nasal spray has not yet been demonstrated to be effective.192-194

The use of zinc supplements in cold prevention is less well studied than their use in cold treatment. In a placebo-controlled trial that included 40 U.S. military cadets, those given 15 mg zinc (as zinc gluconate) daily for seven months reported more weeks without any common cold symptoms.195 Controlled trials in children have found supplementing with 10 mg or 15 mg zinc (as zinc sulfate) daily through the winter months can reduce frequency of common colds and possibly inappropriate use of antibiotics.196

Vitamin C

As an antioxidant, vitamin C helps reduce tissue-damaging oxidative stress caused by immune cell activation, and studies have shown vitamin C levels drop during infections. Restoring vitamin C concentrations may lead to decreased symptom severity and shorten duration of illness.197 Vitamin C supplementation may be especially valuable in athletes, since heavy physical exertion increases oxidative stress and may increase the rate of vitamin C depletion.18,197

In a 30-day randomized controlled trial that included 1,444 military recruits, those who received 6,000 mg vitamin C per day had 20% fewer colds than those who received placebo.198 In a placebo-controlled trial in 28 healthy non-smoking men with marginal vitamin C levels (<45 µmol/L), those given 1,000 mg vitamin C daily for eight weeks had a 45% lower incidence of common colds, and their duration was 59% shorter.199

A meta-analysis of findings from eight randomized controlled trials in children found vitamin C supplementation can shorten the duration of common colds by 1.6 days in this age group.202


Echinacea species (Echinacea purpurea and Echinacea angustifolia) are used in herbal medicine to boost immune function and prevent and treat various acute infections. Extracts from echinacea have been found to modulate immune cell activity and reduce inflammatory signaling in preclinical studies. Echinacea has demonstrated antiviral effects against common cold-causing viruses, including rhinoviruses and influenza viruses.205

In a randomized controlled trial with 755 healthy participants who reported a prior history of two or more cold episodes per year, taking 2,400 mg of an alcohol extract of echinacea daily for four months, and increasing the dose to 4,000 mg daily during acute cold symptoms, resulted in fewer cold episodes and fewer total sick days compared with placebo. The rate of recurrent infections in particular was 59% lower in those treated with echinacea.206

Meta-analyses of randomized controlled trials found use of echinacea extracts can reduce the risk of common colds by 17%–22%.207,208 One meta-analysis that included six randomized controlled trials with a total of 2,458 participants found echinacea reduced the incidence of recurrent upper respiratory infections by approximately 35%. The analysis also noted echinacea may have a stronger protective effect in individuals with increased susceptibility to colds, such as due to stress or weakened immune function, and alcohol extracts appear to be more effective than pressed juices.209 Investigations into the treatment effects of echinacea have yielded mixed results, with uncertain evidence that it can shorten illness duration or limit symptom severity in individuals with colds.207,208


Pelargonium (Pelargonium sidoides) is a medicinal plant native to South Africa and used for centuries to treat respiratory and gastrointestinal infections.210,211 The roots contain numerous compounds with biological activity, and root extracts have demonstrated antiviral, antibacterial, and immune-modulating properties.210,212-214 A standardized alcohol extract of pelargonium, EPs 7630, has been approved for use in treating acute respiratory tract infections in some countries in Europe, Asia, and Central and South America, as well as in Australia.210,211

In a randomized controlled trial, 105 adults with common cold symptoms were treated with 120 mg EPs 7630 per day or placebo for 10 days. Those receiving EPs 7630 experienced faster reduction in symptom severity: by day 10, 74% of those treated with EPs 7630 and 25% of those receiving placebo had no or only one symptom remaining.215 A similar trial found liquid EPs 7630, at a dose of 60 drops three times daily, was also effective for reducing symptom severity and duration in adult common cold patients.216 A meta-analysis of results from five randomized controlled trials that included a total of 833 adults with common colds found treatment with EPs 7630 shortened duration and reduced severity of illness.217 Another meta-analysis included six randomized controlled trials with 523 participants aged 6–10 years and found treatment with pelargonium extract reduced symptoms and accelerated recovery in children with acute sore throat, tonsillitis, and bronchitis.218 Even in children under six years old, seven clinical trials, including two randomized controlled trials, showed EPs 7630 could be a safe and effective option for treating acute upper respiratory tract infections and bronchitis.219


Andrographis (Andrographis paniculata) is used in Ayurvedic and traditional Chinese herbal medicine for treating common colds and flu, sore throat, and fever.220-222 Extracts of andrographis have exhibited immune-stimulating, anti-inflammatory, antiviral, and antibacterial actions in preclinical studies.220,222 In healthy volunteers, andrographis was found to increase the number of immune cells in circulation.223

A randomized controlled trial included 223 patients with upper respiratory infections who received either 200 mg andrographis daily or placebo during the first five days of illness. The andrographis group had greater improvement in overall symptoms, especially during days three through five.224 In another placebo-controlled trial in 185 patients with upper respiratory infections, five days of treatment with a combination of andrographis and Siberian ginseng (Eleutherococcus senticosus) resulted in reduced overall symptom scores, with headache, nasal symptoms, throat symptoms, and malaise being most impacted.225 A meta-analysis of findings from 33 randomized controlled trials found andrographis, alone and in herbal combinations, reduced acute respiratory tract infection symptoms, particularly cough and sore throat, as well as duration of illness.221 Another meta-analysis examined findings from six trials and found andrographis was beneficial for treating cough associated with common colds and other upper respiratory tract infections.226


Several ginseng species, including Korean or red ginseng (Panax ginseng), American ginseng (Panax quinquefolius), and Chinese ginseng (Panax notoginseng), have been studied for their ability to modulate immune function and prevent and treat infections. Although not identical, these ginseng species have similar active constituents and overlap in therapeutic potential.227 Ginseng extracts have shown antiviral actions against influenza viruses and other cold-causing viruses in preclinical studies. In addition, ginseng has been shown to activate the antiviral immune response while reducing the inflammatory response, possibly by lowering oxidative stress.227,228

A popular commercial product that contains a standardized extract of Panax quinquefolius may help prevent and treat colds and flu. A randomized placebo-controlled trial in 323 healthy adults with a history of at least two colds in the previous winter found four months of treatment with 400 mg of the standardized ginseng extract per day reduced the incidence of colds and recurrences, as well as severity and duration of cold symptoms.229 In another randomized controlled trial, 43 individuals aged 65 years and older took either 400 mg of the standardized ginseng extract per day or placebo for four months. In the second half of the trial, 32% of the ginseng group experienced an acute respiratory illness compared with 62% of the placebo group. In addition, the average duration of symptoms in the ginseng group was 5.6 days versus 12.6 days in the placebo group.230 A report on two similar trials found this ginseng extract lowered the risk of acute respiratory infections by 89% compared with placebo in elderly residents of long-term care facilities.231 The same standardized extract of ginseng has also been found to be effective for treating upper respiratory infections in children.232 However, a trial in 293 patients with weakened immune function due to chronic lymphocytic leukemia did not find treatment with this ginseng extract to be effective: although the ginseng-treated group tended to have fewer moderate-to-severe acute respiratory infections, the difference did not reach statistical significance and the total number of respiratory infections was similar in the two groups. The ginseng-treated group had significantly less sore throat compared with placebo.233

A 12-week, randomized, placebo-controlled trial evaluated the effect of 100 mg per day of a standardized extract of red ginseng on the incidence of common cold and flu in 227 healthy individuals. All participants were vaccinated against flu in week four of the study. Ginseng-treated participants had a stronger response to the flu vaccine and a 64% lower number of cold and flu cases than participants given placebo.234 A report on a series of observational studies indicated patients treated with red ginseng were less likely to develop common colds than those not taking ginseng. Red ginseng’s possible cold-preventing impact was thought to be related to its ability to improve immunity by increasing stress resilience.235

Saccharomyces cerevisiae

Saccharomyces cerevisiae (S. cerevisiae) is a probiotic yeast that is consumed in fermented foods such as beer and sourdough bread. It has been hypothesized that S. cerevisiae and other probiotic yeasts may enhance the immune system by improving the physical barrier of the gastrointestinal system and helping regulate cytokine secretion.236 A yeast fermentation product partially derived from S. cerevisiae (EpiCor) has been shown to protect against cold and flu-like symptoms in two clinical trials. In a randomized controlled trial of 116 participants who had not received a recent seasonal influenza vaccine, 500 mg EpiCor daily significantly reduced the incidence of common cold or flu-like symptoms compared with placebo. When symptoms were measured individually, EpiCor significantly reduced 10 out of 11 symptoms, with no effect on weakness. Although the duration of symptoms was numerically reduced from 4.25 to 3.59 symptom days with EpiCor, there was no significant difference in duration in this study.237 When EpiCor was evaluated in 116 recently vaccinated individuals, similar results were reported. EpiCor significantly reduced the incidence of cold or flu-like symptoms as well as the duration of symptoms (from 5.01 to 4.16 days) compared with placebo.238


Garlic (Allium sativum) has a long history of use in preventing and treating infections, and has been shown to exert antimicrobial and immune-enhancing effects in numerous studies.239 In addition to improving the antiviral immune response, sulfur compounds from garlic have demonstrated direct antiviral action.240 In a controlled trial in 120 healthy volunteers, 2.56 grams of aged garlic extract per day for 90 days during cold and flu season resulted in improved immune responsiveness compared with placebo. In addition, aged garlic extract reduced the severity of cold and flu symptoms and number of work days missed due to illness.241 A placebo-controlled trial in 146 adults reported taking 180 mg garlic powder daily for 12 weeks during winter reduced the incidence of common colds by 37% and their duration by 30%.239,242 In a controlled trial, 172 children given 600 mg per day of an extended-release preparation of garlic for five months had two- to four-fold reductions in acute respiratory illnesses compared with 468 untreated controls. In a follow-up placebo-controlled trial that included 156 children, taking 300 mg per day of extended-release garlic for five months resulted in a 1.7-fold decrease in acute respiratory illnesses compared with placebo and was more effective than benzimidazole (a compound with possible antiviral effects).243,244

Green Tea

Green tea (Camellia sinensis) is a rich source of polyphenols known as catechins. Green tea catechins have demonstrated antiviral actions against cold- and flu-causing viruses in preclinical research.245 In a randomized controlled trial in 108 healthy adults, green tea capsules, taken twice daily for three months, reduced the risk of cold and flu illness lasting two days or longer by 22.9% and the number of days with cold or flu symptoms by 35.6% compared with placebo. In addition, immune cells from those receiving green tea exhibited increased antiviral activity.246 In a controlled trial that included 270 healthcare workers, those receiving 171 mg green tea catechins daily for 12 weeks in the winter had a lower rate of upper respiratory infections (13.1%) than those receiving placebo (26.7%).247 Another trial that included 197 healthcare workers found taking 378 mg tea catechins daily, along with 210 mg theanine (another compound from green tea) daily, for five months resulted in fewer influenza virus infections: 4.1% of catechin-treated participants versus 13.1% of participants receiving placebo.248 A study that included 2,050 elementary school students in Japan found, compared with those who drank less than one cup of green tea per day, children who regularly consumed an average of one to less than three cups per day had a 38% lower risk of influenza virus infection and those who consumed 3–5 cups per day had a 46% lower risk.249 In addition, several clinical trials have noted gargling with green tea has a greater protective effect against influenza virus-related illness than gargling with water alone.71


Black elder (Sambucus nigra) has a long history of traditional use in the treatment of colds and flu.250 It has demonstrated antimicrobial properties and shown specific activity against influenza viruses in the laboratory.251,252

One controlled trial enrolled 312 airline passengers travelling overseas on flights lasting seven hours or longer and staying at their destination for four or more days. The participants were given elderberry extract, at a dose of 600 mg per day for 10 days prior to travel and 900 mg per day during time overseas, or placebo. Those receiving elderberry experienced approximately half as many sick days, and symptom severity scores were less than half as high as in those receiving placebo.253 Several other placebo-controlled trials reported treatment with elderberry extract, alone or combined with echinacea extract, reduced symptoms, duration, and other medication use in patients with influenza,254,255 but one found no effect.256

Enzymatically Modified Rice Bran

Enzymatically modified rice bran is made by fermenting rice bran with enzymes extracted from the shiitake mushroom (Lentinus edodes). Through the fermentation process, immunologically active polysaccharides, including one called arabinoxylan, become more bioavailable.257 In a double-blind, placebo-controlled, crossover trial, 36 subjects between 70 and 95 years of age received both 500 mg arabinoxylan and placebo, each for six weeks. Common cold symptom scores were three times higher and duration of symptoms more than twice as long in participants during the placebo phase compared with the arabinoxylan phase. In addition, those with low baseline NK cell activity had a greater increase in NK cell activity during the arabinoxylan phase.258 NK cells clear virus-infected cells and stimulate other aspects of the antiviral immune response.

Arabinoxylan has prebiotic effects and can improve gut microbiome composition by increasing both abundance and diversity of intestinal bacteria. This may, in part, explain how arabinoxylan exerts its positive effects on immune function.259 In addition, arabinoxylan may directly stimulate the activity of a variety of immune cells.261 Taking 3 grams of enzymatically modified rice bran daily for eight weeks was found to raise immune cell production of interferon-γ, a cytokine involved in antiviral defense, in healthy volunteers.257 A study in geriatric subjects found taking 500 mg enzymatically modified rice bran daily for 30 days increased NK cell activity.262


Selenium is necessary for human health mainly due to its incorporation into selenoproteins, such as the antioxidant enzymes glutathione peroxidase and thioredoxin reductase.264 Selenoproteins are needed for a successful antiviral immune response, and selenium deficiency has been linked to worse outcomes in acute and chronic viral infections in preclinical research and observational studies.265,266

In a placebo-controlled trial in 192 subjects with a history of recurrent upper respiratory infections, 16 weeks of treatment with a nutritional supplement that contained selenium, as well as vitamins C and D and folic acid, resulted in reduced cold symptom severity and work days missed.267 In a randomized controlled trial in 108 COPD patients, taking a supplement containing selenium, vitamin C, echinacea, and zinc along with usual treatment for seven days during an acute upper respiratory infection led to less severe and shorter COPD exacerbations.268

Vitamin E

Vitamin E has an important role in immune function, partly due to its ability to protect immune cells from oxidative damage. Deficiency of this lipid-soluble antioxidant impairs immune health, and vitamin E supplementation may improve defense against upper respiratory infections, particularly in the elderly.269,270 Low vitamin E levels have been correlated with acute and recurrent respiratory tract infections in children.271-273 Some studies suggest higher dietary vitamin E intake and supplement use may reduce the risk of upper respiratory infection in adults,135,274 but may have no benefit or even cause harm in heavy smokers.275

A clinical trial in 33 elderly individuals found taking a supplement providing 200 mg (180 IU) of dl-alpha-tocopherol (a form of vitamin E) per day for three months improved immune cell function.276 However, in 652 healthy community-based older individuals, 200 IU daily of vitamin E did not decrease the risk of acute respiratory infections and appeared to increase symptom severity.278 Further study is necessary to understand vitamin E’s role in upper respiratory infections.


Lactoferrin is an iron-binding protein made by cells such as those in secretory glands and activated neutrophils (a type of immune cell). It is found in most body fluids, including tears and breast milk, and lactoferrin derived from bovine whey is frequently used in supplements. Lactoferrin possesses immune-modulating effects, capable of enhancing anti-microbial immune activity while reducing inflammation, and has exhibited a broad spectrum of activity against bacteria, fungi, protozoa, and viruses. Laboratory studies have shown lactoferrin inhibits certain viruses, including some cold-causing viruses and influenza viruses, from binding to cell receptor sites, preventing their entry into host cells, and suppresses viral replication inside infected cells. In addition, lactoferrin sequesters pro-oxidant iron and decreases pro-inflammatory molecules released during the immune response to infection. Because of its immune-modulating and antiviral properties, lactoferrin has even attracted interest as a potential therapy for preventing or treating some severe viral respiratory infections.279

In a randomized controlled trial, 90 subjects with a history of frequent common colds were given either 600 mg per day lactoferrin in a bovine whey extract or placebo for 90 days. There were 48 colds in the lactoferrin group and 112 in the placebo group during the study period, and the total number of cold symptoms was lower in the lactoferrin group.282 Another 90-day controlled trial found lactoferrin supplementation reduced the number of common cold symptoms reported by participants.283

Cystine and Theanine

L-cystine and L-theanine are non-essential amino acids that appear to modulate immune cell activity by enhancing production of the preeminent antioxidant, glutathione. Glutathione levels are known to decrease as a result of stressors such as intense exercise.284 In a randomized controlled trial, 173 healthy men received either 700 mg L-cystine and 280 mg L-theanine or placebo daily for 35 days. The incidence of common colds was 27.1% in the placebo group, with 23 colds occurring during the trial, while the incidence was 11.4% in the L-cysteine and L-theanine group, with only 10 colds occurring during the trial.285

L-cystine and L-theanine may have especially beneficial effects in preserving strong immune function in athletes. A trial in 16 long-distance runners showed supplementing with L-cysteine and L-theanine (700 mg and 280 mg per day, respectively) for seven days prior to and nine days during a training program suppressed alterations in immune function induced by intense exercise, possibly by reducing exercise-induced oxidative stress and inflammation.286 Other trials in athletes add to the evidence that L-cysteine and L-theanine supplementation during training reduces inflammation and prevents potentially detrimental changes in immune function.284,288


Quercetin is a flavonoid with anti-inflammatory, antioxidant, and antiviral properties. It is naturally found in foods such as apples, grapes, broccoli, kale, red onions, green tea, and wine. Research suggests quercetin may decrease infection risk, prevent histamine release, and support balanced immune cell activity.290,291 Quercetin has been shown to inhibit replication and infectivity of cold-causing viruses and reduce inflammation induced by viral infection.341

A randomized, double-blind, placebo-controlled trial of over 1,000 people compared 12 weeks of placebo and quercetin (at 500 and 1,000 mg/day, with 500‒1,000 mg vitamin C and 20‒40 mg niacin) in reducing rates of upper respiratory tract infections. While there was no significant difference in infection rate for all subjects (aged 18 to 85 years), a separate analysis of physically fit individuals aged 40 years and older found 1,000 mg quercetin daily reduced upper respiratory infection severity and number of sick days reported.293 A randomized, double-blind, placebo-controlled study in which 40 trained male cyclists were given either quercetin (1,000 mg/day) or placebo one week before, during, and two weeks after a three-day period of intense exercise (three hours of cycling per day) found quercetin significantly reduced upper respiratory infection incidence in the two weeks after intense exercise.294

Fish Oil

Fish oil is rich in omega-3 polyunsaturated fatty acids and is a source of vitamins A and D. Two omega-3 fatty acids from fish, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have well known anti-inflammatory effects, and evidence suggests metabolites of DHA may have direct antiviral activity.295 In a laboratory model of rhinovirus infection, omega-3 fatty acids reduced the inflammatory response while arachidonic acid (an omega-6 fatty acid) and saturated fatty acids from animal fat increased inflammatory signaling.297 Some studies show higher intake of EPA and DHA during infancy and early childhood is associated with better respiratory health.298 In children, taking cod liver oil plus a multivitamin/mineral supplement was reported to result in reduced doctor visits for upper respiratory infections by 36–58%.299

Vitamin A

Vitamin A has a fundamental role in developing and regulating mucosal immunity, interacting with immune cells and the microbiome to maintain a balanced immune response and promote tolerance.300 Vitamin A deficiency has been linked to increased risk of acute and recurrent respiratory infections, particularly in children.271,273 Large trials in populations of children at risk for vitamin A deficiency have shown supplementation can lower childhood illnesses and mortality.301 However, it is unclear whether vitamin A supplements are beneficial in treatment of respiratory infections, even in children at risk of deficiency.302


Cistanche (Cistanche deserticola) is a medicinal plant that has been used historically as a remedy for chronic infections and other illnesses. Cistanche contains an array of bioactive compounds, some of which have been shown to have antiviral and immunomodulatory properties.303,304 In an animal model of aging and immune senescence, cistanche extract was found to reverse indicators of immune dysfunction and extend lifespan.44

In a 12-week trial in 25 elderly individuals, taking 100 mg cistanche extract daily in a product that also contained vitamin E, vitamin B6, coenzyme Q10, zinc, and fucoidan, led to improvements in relative numbers and activity of immune cells. There were also improvements in tests of vascular function, and study volunteers reported decreased fatigue.305


Although best known for its role in circadian system regulation, melatonin is also produced by immune cells and participates in activation of antimicrobial defenses, reducing inflammatory signaling, and lowering oxidative stress.307 Melatonin production diminishes with age, contributing to higher oxidative stress, inflammation, and infection susceptibility.309

In light of its safety and anti-inflammatory effects, there is growing interest in the possible preventive and therapeutic use of melatonin in viral respiratory illnesses such as influenza. The elderly and those with chronic medical conditions, who are at higher risk for severe illness and complications, may benefit most from regular use of 3–10 mg melatonin at bedtime.337


Astragalus (Astragalus membranaceus), known as Huang Qi in traditional Chinese herbal medicine, has been used for centuries as a tonic to prolong life and treat a wide variety of conditions, including infections and fatigue.311,312 Its medicinal effects are attributed to immune-stimulating polysaccharides, flavonoids, and saponins found in its roots.311,313,314 Preclinical research indicates astragalus extracts can enhance mucosal immunity and activate immune cells, and a pilot trial in humans found an astragalus extract reversed markers of immune senescence.311,312,315


Reishi mushroom (Ganoderma lucidum) has been used for centuries in traditional Chinese medicine for its health-promoting and anti-aging effects. It contains compounds that improve immune function, increase antioxidant capacity, reduce inflammation, and build defenses against infections and cancer.46,316 Its polysaccharides in particular have been found to enhance non-specific immune surveillance, as well as specific pathogen-recognizing immune activity. Reishi may further regulate immune function through its effects on immune tissues and cytokine production.317 Extracts from reishi have also demonstrated direct antiviral activity.316,318 Because of its broad anti-aging and immune-modulating properties, reishi may reduce the risk of viral respiratory infections, especially in the elderly and those with compromised immune function.

Ellagic Acid

Ellagic acid is a polyphenolic compound found in the peels and seeds of pomegranates as well as in grapes, strawberries, and raspberries. Ellagic acid and other polyphenols have been shown to promote immunity by neutralizing free radicals and protecting cells from oxidative stress. These effects are believed to contribute to anti-inflammatory, anticancer, and antiaging effects.319 Extracts of ellagic acid made from crepe myrtles have been shown to have antiviral properties, preventing human rhinovirus infection in laboratory experiments.320 Ellagic acid has also shown activity against influenza virus, hepatitis C virus, and Zika virus in laboratory models.321-323 Assessments in humans are needed to determine the effectiveness of ellagic acid for preventing or treating cold and flu-like symptoms.


Dehydroepiandrosterone (DHEA) is a steroid hormone synthesized by the adrenal gland that has a complex role in immune regulation and controlling the inflammatory process.324 DHEA levels decline with age, and this may be a contributing factor in immune senescence.325,326

DHEA supplementation has been found to activate immune cells involved in antiviral defense in preclinical research and clinical trials in elderly subjects.325,327 DHEA has also been found to reduce inflammation and protect against lethal viral, bacterial, and parasitic infections in laboratory animals.328-331 Despite its importance in antimicrobial immune activity, levels of DHEA-sulfate (the main circulating form of DHEA) can be diminished during acute severe infections, and some research suggests DHEA levels may be suppressed for two weeks or longer after a critical illness or injury.332 This is because during physiologic stress, such as infection or trauma, adrenal cortisol production rises at the expense of DHEA production. The resulting high cortisol to DHEA-sulfate ratio has been linked to poor outcomes, especially in individuals whose immune function is already altered by aging.333 Clinical trials have shown 50–100 mg DHEA daily for up to one year can have various anti-aging effects.327

Annona muricata

Annona muricata (A. muricata), also known as soursop or graviola, is a tropical tree that produces edible fruit. Its leaves, stems, roots, and fruits have been used in traditional medicine across the globe. The plant contains high levels of flavonoids, alkaloids, and phenolic and lipophilic compounds that are believed to exert antiviral, antioxidant, and anti-inflammatory properties.334 In laboratory experiments, A. muricata extracts have been shown to inhibit the replication of Dengue virus and bacteriophages, which are a viral model for enteroviruses.334,335 Rutin is one of the main flavonoids found in A. muricata, and a derivative of rutin (troxerutin) combined with zinc gluconate was shown to reduce the incidence of runny nose in a study of 94 participants with common cold symptoms.336

Disclaimer and Safety Information

This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a physician or other qualified health care professional. Pregnant women in particular should seek the advice of a physician before using any protocol listed on this website. The protocols described on this website are for adults only, unless otherwise specified. Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications. National, state, and local laws may vary regarding the use and application of many of the therapies discussed. The reader assumes the risk of any injuries. The authors and publishers, their affiliates and assigns are not liable for any injury and/or damage to persons arising from this protocol and expressly disclaim responsibility for any adverse effects resulting from the use of the information contained herein.

The protocols raise many issues that are subject to change as new data emerge. None of our suggested protocol regimens can guarantee health benefits. Life Extension has not performed independent verification of the data contained in the referenced materials, and expressly disclaims responsibility for any error in the literature.

  1. Sexton DJM, M. T. UpToDate. The common cold in adults: Diagnosis and clinical features. Last updated 12/27/19. Accessed 09/18/20. . 2019;
  2. CDC. Centers for Disease Control and Prevention: Flu Symptoms and Complications. Available at Last updated 08/31/20. Accessed 09/22/20. 2020;
  3. Kardos P, Malek FA. Common Cold - an Umbrella Term for Acute Infections of Nose, Throat, Larynx and Bronchi. Pneumologie (Stuttgart, Germany) . Apr 2017;71(4):221-226. Erkältung – ein Sammelbegriff für akute Infektionen von Nase, Rachen, Kehlkopf und Bronchien. doi:10.1055/s-0042-116112
  4. Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: A narrative review. Tobacco induced diseases. 2020;18:60. doi:10.18332/tid/123845
  5. Thomas M, Koutsothanasis GA, Bomar PA. Upper Respiratory Tract Infection. StatPearls. StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC.; 2020.
  6. Papadopoulos NG, Megremis S, Kitsioulis NA, Vangelatou O, West P, Xepapadaki P. Promising approaches for the treatment and prevention of viral respiratory illnesses. The Journal of allergy and clinical immunology. Oct 2017;140(4):921-932. doi:10.1016/j.jaci.2017.07.001
  7. Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients. Apr 23 2020;12(4)doi:10.3390/nu12041181
  8. Grienke U, Mair CE, Kirchmair J, Schmidtke M, Rollinger JM. Discovery of Bioactive Natural Products for the Treatment of Acute Respiratory Infections - An Integrated Approach. Planta Med. Jul 2018;84(9-10):684-695. doi:10.1055/a-0590-5153
  9. Naithani R, Huma LC, Holland LE, et al. Antiviral activity of phytochemicals: a comprehensive review. Mini Rev Med Chem. Oct 2008;8(11):1106-33. doi:10.2174/138955708785909943
  10. Jaume F, Valls-Mateus M, Mullol J. Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020. Current allergy and asthma reports. Jun 3 2020;20(7):28. doi:10.1007/s11882-020-00917-5
  11. Rondanelli M, Miccono A, Lamburghini S, et al. Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evidence-based complementary and alternative medicine : eCAM. 2018;2018:5813095. doi:10.1155/2018/5813095
  12. Fashner J, Ericson K, Werner S. Treatment of the common cold in children and adults. American family physician. Jul 15 2012;86(2):153-9.
  13. Sexton DJM, M. T. UpToDate: The common cold in adults: treatment and prevention. Last updated 03/24/20. Accessed 09/18/20. . 2020;
  14. Basnet S, Palmenberg AC, Gern JE. Rhinoviruses and Their Receptors. Chest. May 2019;155(5):1018-1025. doi:10.1016/j.chest.2018.12.012
  15. To KKW, Yip CCY, Yuen KY. Rhinovirus - From bench to bedside. Journal of the Formosan Medical Association = Taiwan yi zhi. Jul 2017;116(7):496-504. doi:10.1016/j.jfma.2017.04.009
  16. van Doorn HR, Yu H. Viral Respiratory Infections. Hunter's Tropical Medicine and Emerging Infectious Diseases. 2020:284-288. doi:10.1016/B978-0-323-55512-8.00033-8
  17. Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of Respiratory Viral Infections. Annu Rev Virol. Mar 20 2020;doi:10.1146/annurev-virology-012420-022445
  18. 32. Aiello A, Farzaneh F, Candore G, et al. Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention. Review. Frontiers in Immunology. 2019-September-25 2019;10(2247)doi:10.3389/fimmu.2019.02247
  19. Fulop T, Franceschi C, Hirokawa K, Pawelec G, Loeb M. Immunosenescence and Respiratory Infections Among Nursing Home Residents. Handbook of ImmunosenescenceBasic Understanding and Clinical Implications . 2019/04// 2019:1789-1797.
  20. Gómez-Rubio P, Trapero I. The beneficial effect of physical exercise on inflammatory makers in older individuals. Endocr Metab Immune Disord Drug Targets. Jun 6 2020;doi:10.2174/1871530320666200606225357
  21. Ciolac EG, Rodrigues da Silva JM, Vieira RP. Physical Exercise as an Immunomodulator of Chronic Diseases in Aging. J Phys Act Health. May 11 2020:1-11. doi:10.1123/jpah.2019-0237
  22. Walker ME, Song RJ, Xu X, et al. Proteomic and Metabolomic Correlates of Healthy Dietary Patterns: The Framingham Heart Study. Nutrients. May 19 2020;12(5)doi:10.3390/nu12051476
  23. Clements SJ, Maijo M, Ivory K, Nicoletti C, Carding SR. Age-Associated Decline in Dendritic Cell Function and the Impact of Mediterranean Diet Intervention in Elderly Subjects. Frontiers in nutrition. 2017;4:65. doi:10.3389/fnut.2017.00065
  24. Brandhorst S, Longo VD. Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity. Adv Nutr. Nov 1 2019;10(Suppl_4):S340-s350. doi:10.1093/advances/nmz079
  25. Kraus WE, Bhapkar M, Huffman KM, et al. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. The lancet Diabetes & endocrinology. Sep 2019;7(9):673-683. doi:10.1016/s2213-8587(19)30151-2
  26. Stekovic S, Hofer SJ, Tripolt N, et al. Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans. Cell metabolism. Sep 3 2019;30(3):462-476.e6. doi:10.1016/j.cmet.2019.07.016
  27. Meydani SN, Das SK, Pieper CF, et al. Long-term moderate calorie restriction inhibits inflammation without impairing cell-mediated immunity: a randomized controlled trial in non-obese humans. Aging (Albany NY). Jul 2016;8(7):1416-31. doi:10.18632/aging.100994
  28. Hardeland R. Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks. International journal of molecular sciences. Mar 11 2019;20(5)doi:10.3390/ijms20051223
  29. Zhang K, Ma X, He W, et al. Extracts of Cistanche deserticola Can Antagonize Immunosenescence and Extend Life Span in Senescence-Accelerated Mouse Prone 8 (SAM-P8) Mice. Evidence-based complementary and alternative medicine : eCAM. 2014;2014:601383. doi:10.1155/2014/601383
  30. Zhang L, Shao WF, Yuan LF, Tu PF, Ma ZZ. Decreasing pro-inflammatory cytokine and reversing the immunosenescence with extracts of Pu-erh tea in senescence accelerated mouse (SAM). Food Chem. Dec 15 2012;135(4):2222-8. doi:10.1016/j.foodchem.2012.07.033
  31. Pan Y, Lin Z. Anti-aging Effect of Ganoderma (Lingzhi) with Health and Fitness. Adv Exp Med Biol. 2019;1182:299-309. doi:10.1007/978-981-32-9421-9_13
  32. Yan J, Grantham M, Pantelic J, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc Natl Acad Sci U S A. Jan 30 2018;115(5):1081-1086. doi:10.1073/pnas.1716561115
  33. La Rosa G, Fratini M, Della Libera S, Iaconelli M, Muscillo M. Viral infections acquired indoors through airborne, droplet or contact transmission. Annali dell'Istituto superiore di sanita. 2013;49(2):124-32. doi:10.4415/ann_13_02_03
  34. Atkinson SK, Sadofsky LR, Morice AH. How does rhinovirus cause the common cold cough? BMJ Open Respir Res. 2016;3(1):e000118. doi:10.1136/bmjresp-2015-000118
  35. Bauer CMT, Morissette MC, Stämpfli MR. The influence of cigarette smoking on viral infections: translating bench science to impact COPD pathogenesis and acute exacerbations of COPD clinically. Chest. Jan 2013;143(1):196-206. doi:10.1378/chest.12-0930
  36. Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest. Oct 2006;130(4):1203-10. doi:10.1378/chest.130.4.1203
  37. Turner RB. The Common Cold. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases . 2015:748-752.e2. doi:10.1016/B978-1-4557-4801-3.00058-8
  38. Moore A, Harnden A, Grant CC, Patel S, Irwin RS, Panel CEC. Clinically Diagnosing Pertussis-associated Cough in Adults and Children: CHEST Guideline and Expert Panel Report. Chest. 2019;155(1):147-154. doi:10.1016/j.chest.2018.09.027
  39. Franzese CB. AAOA allergy primer: history and physical examination. International forum of allergy & rhinology. Sep 2014;4 Suppl 2:S28-31. doi:10.1002/alr.21390
  40. HHP. Harvard Health Publishing. Acute Bronchitis. Available at Last updated 05/07/20. Accessed 09/22/20. 2018;
  41. Covington EW, Roberts MZ, Dong J. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature. Pharmacotherapy. May 2018;38(5):569-581. doi:10.1002/phar.2112
  42. Branche A, Neeser O, Mueller B, Schuetz P. Procalcitonin to guide antibiotic decision making. Current opinion in infectious diseases . Apr 2019;32(2):130-135. doi:10.1097/qco.0000000000000522
  43. Dilger AE, Peters AT, Wunderink RG, et al. Procalcitonin as a Biomarker in Rhinosinusitis: A Systematic Review. American journal of rhinology & allergy. Mar 2019;33(2):103-112. doi:10.1177/1945892418810293
  44. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. The Cochrane database of systematic reviews. Jul 6 2011;2011(7):Cd006207. doi:10.1002/14651858.CD006207.pub4
  45. Kurgat EK, Sexton JD, Garavito F, et al. Impact of a hygiene intervention on virus spread in an office building. Int J Hyg Environ Health. Apr 2019;222(3):479-485. doi:10.1016/j.ijheh.2019.01.001
  46. Winther B, McCue K, Ashe K, Rubino J, Hendley JO. Rhinovirus contamination of surfaces in homes of adults with natural colds: transfer of virus to fingertips during normal daily activities. Journal of medical virology. May 2011;83(5):906-9. doi:10.1002/jmv.22027
  47. Thompson KA, Bennett AM. Persistence of influenza on surfaces. The Journal of hospital infection. Feb 2017;95(2):194-199. doi:10.1016/j.jhin.2016.12.003
  48. Tamimi AH, Maxwell S, Edmonds SL, Gerba CP. Impact of the use of an alcohol-based hand sanitizer in the home on reduction in probability of infection by respiratory and enteric viruses. Epidemiol Infect. Nov 2015;143(15):3335-41. doi:10.1017/s0950268815000035
  49. Satomura K, Kitamura T, Kawamura T, et al. Prevention of upper respiratory tract infections by gargling: a randomized trial. Am J Prev Med. Nov 2005;29(4):302-7. doi:10.1016/j.amepre.2005.06.013
  50. Noda T, Ojima T, Hayasaka S, Murata C, Hagihara A. Gargling for oral hygiene and the development of fever in childhood: a population study in Japan. Journal of epidemiology. 2012;22(1):45-9. doi:10.2188/jea.je20100181
  51. Ide K, Yamada H, Kawasaki Y. Effect of gargling with tea and ingredients of tea on the prevention of influenza infection: a meta-analysis. BMC Public Health. May 12 2016;16:396. doi:10.1186/s12889-016-3083-0
  52. Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. Jul 15 2020;12(7)doi:10.3390/nu12072097
  53. Wang MX, Koh J, Pang J. Association between micronutrient deficiency and acute respiratory infections in healthy adults: a systematic review of observational studies. Nutr J. Nov 30 2019;18(1):80. doi:10.1186/s12937-019-0507-6
  54. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. Jun 14 2010;5(6):e11088. doi:10.1371/journal.pone.0011088
  55. Marr LC, Tang JW, Van Mullekom J, Lakdawala SS. Mechanistic insights into the effect of humidity on airborne influenza virus survival, transmission and incidence. J R Soc Interface. Jan 31 2019;16(150):20180298. doi:10.1098/rsif.2018.0298
  56. Wolkoff P. Indoor air humidity, air quality, and health - An overview. Int J Hyg Environ Health. Apr 2018;221(3):376-390. doi:10.1016/j.ijheh.2018.01.015
  57. Yang W, Marr LC. Mechanisms by which ambient humidity may affect viruses in aerosols. Appl Environ Microbiol. Oct 2012;78(19):6781-8. doi:10.1128/aem.01658-12
  58. Kudo E, Song E, Yockey LJ, et al. Low ambient humidity impairs barrier function and innate resistance against influenza infection. Proc Natl Acad Sci U S A. May 28 2019;116(22):10905-10910. doi:10.1073/pnas.1902840116
  59. Ikäheimo TM, Jaakkola K, Jokelainen J, et al. A Decrease in Temperature and Humidity Precedes Human Rhinovirus Infections in a Cold Climate. Viruses. Sep 2 2016;8(9)doi:10.3390/v8090244
  60. Noti JD, Blachere FM, McMillen CM, et al. High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs. PLOS ONE. 2013;8(2):e57485. doi:10.1371/journal.pone.0057485
  61. Arundel AV, Sterling EM, Biggin JH, Sterling TD. Indirect health effects of relative humidity in indoor environments. Environ Health Perspect. Mar 1986;65:351-61. doi:10.1289/ehp.8665351
  62. Myatt TA, Kaufman MH, Allen JG, MacIntosh DL, Fabian MP, McDevitt JJ. Modeling the airborne survival of influenza virus in a residential setting: the impacts of home humidification. Environmental health : a global access science source. Sep 3 2010;9:55. doi:10.1186/1476-069x-9-55
  63. King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. The Cochrane database of systematic reviews. Apr 20 2015;(4):Cd006821. doi:10.1002/14651858.CD006821.pub3
  64. Ramalingam S, Graham C, Dove J, Morrice L, Sheikh A. A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Sci Rep. Jan 31 2019;9(1):1015. doi:10.1038/s41598-018-37703-3
  65. Köksal T, Çizmeci MN, Bozkaya D, et al. Comparison between the use of saline and seawater for nasal obstruction in children under 2 years of age with acute upper respiratory infection. Turkish journal of medical sciences. Jun 23 2016;46(4):1004-13. doi:10.3906/sag-1507-18
  66. Macknin ML, Mathew S, Medendorp SV. Effect of inhaling heated vapor on symptoms of the common cold. Jama. Aug 22-29 1990;264(8):989-91.
  67. Forstall GJ, Macknin ML, Yen-Lieberman BR, Medendorp SV. Effect of Inhaling Heated Vapor on Symptoms of the Common Cold. JAMA. 1994;271(14):1109-1111. doi:10.1001/jama.1994.03510380065039
  68. Ophir D, Elad Y, Fink A, Fishler E, Marshak G. Effects of elevated intranasal temperature on subjective and objective findings in perennial rhinitis. Ann Otol Rhinol Laryngol. May-Jun 1988;97(3 Pt 1):259-63. doi:10.1177/000348948809700309
  69. Hendley JO, Abbott RD, Beasley PP, Gwaltney JM, Jr. Effect of inhalation of hot humidified air on experimental rhinovirus infection. Jama. Apr 13 1994;271(14):1112-3.
  70. Kim SY, Chang YJ, Cho HM, Hwang YW, Moon YS. Non-steroidal anti-inflammatory drugs for the common cold. The Cochrane database of systematic reviews. Sep 21 2015;(9):Cd006362. doi:10.1002/14651858.CD006362.pub4
  71. Sterrantino C, Duarte G, Costa J, Vaz-Carneiro A. [Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345]. Acta medica portuguesa. Mar 2016;29(3):164-7. Análise da Revisão Cochrane: Antihistamínicos para a Constipação. Cochrane Database Syst Rev. 2015;11:CD009345. doi:10.20344/amp.7526
  72. Salisbury-Afshar E. Oral antihistamine/decongestant/analgesic combinations for the common cold. American family physician. Nov 1 2012;86(9):812-3.
  73. Smith SM, Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. The Cochrane database of systematic reviews. Jan 23 2008;(1):Cd001831. doi:10.1002/14651858.CD001831.pub3
  74. Malesker MA, Callahan-Lyon P, Ireland B, Irwin RS. Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report. Chest. Nov 2017;152(5):1021-1037. doi:10.1016/j.chest.2017.08.009
  75. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Annals of emergency medicine. Jul 1999;34(1):8-18. doi:10.1016/s0196-0644(99)70266-0
  76. AlBalawi ZH, Othman SS, Alfaleh K. Intranasal ipratropium bromide for the common cold. The Cochrane database of systematic reviews. Jun 19 2013;2013(6):Cd008231. doi:10.1002/14651858.CD008231.pub3
  77. Aberg N, Aberg B, Alestig K. The effect of inhaled and intranasal sodium cromoglycate on symptoms of upper respiratory tract infections. Clin Exp Allergy. Sep 1996;26(9):1045-50. doi:10.1111/j.1365-2222.1996.tb00642.x
  78. Sarti W, Gomes-Monteiro LA, Magalhães Machado CS. The treatment of allergic rhinitis improves the recovery from asthma and upper respiratory infections. Sao Paulo Med J. Sep-Oct 1995;113(5):968-72. doi:10.1590/s1516-31801995000500002
  79. Miyatake A, Fujita M, Nagasaka Y, et al. The new role of disodium cromoglycate in the treatment of adults with bronchial asthma. Allergology international : official journal of the Japanese Society of Allergology . Sep 2007;56(3):231-9. doi:10.2332/allergolint.O-06-444
  80. NLM. National Library of Medicine. Medline Plus: Cimetidine. Available at Last updated 04/15/2020. Accessed 11/06/2020. 2020;
  81. Jafarzadeh A, Nemati M, Khorramdelazad H, Hassan ZM. Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases. International immunopharmacology. May 2019;70:156-166. doi:10.1016/j.intimp.2019.02.026
  82. Zhang Y, Chen Z, Luo X, Wu B, Li B, Wang B. Cimetidine down-regulates stability of Foxp3 protein via Stub1 in Treg cells. Human vaccines & immunotherapeutics. Oct 02 2016;12(10):2512-2518. doi:10.1080/21645515.2016.1191719
  83. Patel D, Bertz R, Ren S, Boulton DW, Någård M. A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug-Drug Interactions with Orally Administered Medications. Clinical pharmacokinetics. Apr 2020;59(4):447-462. doi:10.1007/s40262-019-00844-3
  84. Simancas-Racines D, Franco JV, Guerra CV, Felix ML, Hidalgo R, Martinez-Zapata MJ. Vaccines for the common cold. The Cochrane database of systematic reviews. May 18 2017;5(5):Cd002190. doi:10.1002/14651858.CD002190.pub5
  85. Casanova V, Sousa FH, Stevens C, Barlow PG. Antiviral therapeutic approaches for human rhinovirus infections. Future virology. Jul 2018;13(7):505-518. doi:10.2217/fvl-2018-0016
  86. Mirabelli C, Scheers E, Neyts J. Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis. F1000Research. 2017;6:1860. doi:10.12688/f1000research.11978.1
  87. Agoni C, Ramharack P, Munsamy G, Soliman MES. Human Rhinovirus Inhibition Through Capsid "Canyon" Perturbation: Structural Insights into The Role of a Novel Benzothiophene Derivative. Cell Biochem Biophys. Mar 2020;78(1):3-13. doi:10.1007/s12013-019-00896-z
  88. Pevear DC, Hayden FG, Demenczuk TM, Barone LR, McKinlay MA, Collett MS. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrob Agents Chemother. Nov 2005;49(11):4492-9. doi:10.1128/aac.49.11.4492-4499.2005
  89. Hayden FG, Herrington DT, Coats TL, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America . Jun 15 2003;36(12):1523-32. doi:10.1086/375069
  90. Schwartz RA, Sinha S, Kapila R, Velazquez A, Dua P. Enteroviruses Follow-up. MedScape. Updated 06/23/2020. Accessed 01/20/2021,
  91. Feldman C, Anderson R. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. The Journal of infection. Sep 2013;67(3):169-84. doi:10.1016/j.jinf.2013.05.004
  92. Hwang JH, Lyes M, Sladewski K, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. Journal of molecular medicine (Berlin, Germany). Jun 2016;94(6):667-79. doi:10.1007/s00109-016-1378-3
  93. Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol. Jul 15 2015;309(2):L175-87. doi:10.1152/ajplung.00411.2014
  94. Zhou G, Liu H, He M, et al. Smoking, leisure-time exercise and frequency of self-reported common cold among the general population in northeastern China: a cross-sectional study. BMC Public Health. Feb 27 2018;18(1):294. doi:10.1186/s12889-018-5203-5
  95. Nieman DC, Wentz LM. The compelling link between physical activity and the body's defense system. Journal of sport and health science. 2019/05/01/ 2019;8(3):201-217. doi:
  96. Campbell JP, Turner JE. Debunking the Myth of Exercise-Induced Immune Suppression: Redefining the Impact of Exercise on Immunological Health Across the Lifespan. Front Immunol. 2018;9:648. doi:10.3389/fimmu.2018.00648
  97. Chubak J, McTiernan A, Sorensen B, et al. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. Am J Med. Nov 2006;119(11):937-42. doi:10.1016/j.amjmed.2006.06.033
  98. Wilder-Smith A, Mustafa FB, Earnest A, Gen L, Macary PA. Impact of partial sleep deprivation on immune markers. Sleep Med. Oct 2013;14(10):1031-4. doi:10.1016/j.sleep.2013.07.001
  99. Wentz LM, Ward MD, Potter C, et al. Increased Risk of Upper Respiratory Infection in Military Recruits Who Report Sleeping Less Than 6 h per night. Military medicine. Nov 1 2018;183(11-12):e699-e704. doi:10.1093/milmed/usy090
  100. Prather AA, Janicki-Deverts D, Hall MH, Cohen S. Behaviorally Assessed Sleep and Susceptibility to the Common Cold. Sleep. 2015;38(9):1353-9. doi:10.5665/sleep.4968
  101. Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D, Turner RB. Sleep habits and susceptibility to the common cold. Arch Intern Med. Jan 12 2009;169(1):62-7. doi:10.1001/archinternmed.2008.505
  102. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. The New England journal of medicine. Aug 29 1991;325(9):606-12. doi:10.1056/nejm199108293250903
  103. Cohen S, Frank E, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM, Jr. Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol. May 1998;17(3):214-23. doi:10.1037//0278-6133.17.3.214
  104. Cohen S, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM, Jr. Social ties and susceptibility to the common cold. Jama. Jun 25 1997;277(24):1940-4.
  105. Maxwell L, Barrett B, Chase J, Brown R, Ewers T. Self-Reported Mental Health Predicts Acute Respiratory Infection. Wmj. Jun 2015;114(3):100-4.
  106. Runeson-Broberg R, Norbäck D. Work-related psychosocial stress as a risk factor for asthma, allergy, and respiratory infections in the Swedish workforce. Psychol Rep. Apr 2014;114(2):377-89. doi:10.2466/15.14.PR0.114k20w3
  107. Brown RL, Shahane AD, Chen MA, Fagundes CP. Cognitive reappraisal and nasal cytokine production following experimental rhinovirus infection. Brain Behav Immun Health. Jan 2020;1doi:10.1016/j.bbih.2019.100012
  108. Barrett B, Hayney MS, Muller D, et al. Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial. Annals of family medicine. Jul-Aug 2012;10(4):337-46. doi:10.1370/afm.1376
  109. Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of the immune response. The Journal of allergy and clinical immunology. Jun 2005;115(6):1119-28; quiz 1129. doi:10.1016/j.jaci.2005.04.036
  110. Calatayud FM, Calatayud B, Gallego JG, González-Martín C, Alguacil LF. Effects of Mediterranean diet in patients with recurring colds and frequent complications. Allergologia et immunopathologia. Sep-Oct 2017;45(5):417-424. doi:10.1016/j.aller.2016.08.006
  111. Li L, Werler MM. Fruit and vegetable intake and risk of upper respiratory tract infection in pregnant women. Public health nutrition. Feb 2010;13(2):276-82. doi:10.1017/s1368980009990590
  112. Fondell E, Bälter O, Rothman KJ, Bälter K. Dietary intake and supplement use of vitamins C and E and upper respiratory tract infection. J Am Coll Nutr. Aug 2011;30(4):248-58. doi:10.1080/07315724.2011.10719967
  113. Hunter DC, Skinner MA, Wolber FM, et al. Consumption of gold kiwifruit reduces severity and duration of selected upper respiratory tract infection symptoms and increases plasma vitamin C concentration in healthy older adults. The British journal of nutrition. Oct 2012;108(7):1235-45. doi:10.1017/s0007114511006659
  114. Roll S, Nocon M, Willich SN. Reduction of common cold symptoms by encapsulated juice powder concentrate of fruits and vegetables: a randomised, double-blind, placebo-controlled trial. The British journal of nutrition. Jan 2011;105(1):118-22. doi:10.1017/s000711451000317x
  115. Ritz T, Werchan CA, Kroll JL, Rosenfield D. Beetroot juice supplementation for the prevention of cold symptoms associated with stress: A proof-of-concept study. Physiology & behavior. Apr 1 2019;202:45-51. doi:10.1016/j.physbeh.2019.01.015
  116. Kwon YS, Park YK, Chang HJ, Ju SY. Relationship Between Plant Food (Fruits, Vegetables, and Kimchi) Consumption and the Prevalence of Rhinitis Among Korean Adults: Based on the 2011 and 2012 Korea National Health and Nutrition Examination Survey Data. Journal of medicinal food. Dec 2016;19(12):1130-1140. doi:10.1089/jmf.2016.3760
  117. Pu F, Guo Y, Li M, et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial. Clin Interv Aging. 2017;12:1223-1231. doi:10.2147/cia.s141518
  118. Kok CR, Hutkins R. Yogurt and other fermented foods as sources of health-promoting bacteria. Nutrition reviews. Dec 1 2018;76(Suppl 1):4-15. doi:10.1093/nutrit/nuy056
  119. Hanada S, Pirzadeh M, Carver KY, Deng JC. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol. 2018;9:2640. doi:10.3389/fimmu.2018.02640
  120. Zhang N, He QS. Commensal Microbiome Promotes Resistance to Local and Systemic Infections. Chin Med J (Engl). Aug 20 2015;128(16):2250-5. doi:10.4103/0366-6999.162502
  121. Karl JP, Hatch AM, Arcidiacono SM, et al. Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota. Front Microbiol. 2018;9:2013. doi:10.3389/fmicb.2018.02013
  122. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. Feb 3 2015;(2):Cd006895. doi:10.1002/14651858.CD006895.pub3
  123. Lee JT, Kim CM, Ramakrishnan V. Microbiome and disease in the upper airway. Current opinion in allergy and clinical immunology. Feb 2019;19(1):1-6. doi:10.1097/aci.0000000000000495
  124. Pichon M, Lina B, Josset L. Impact of the Respiratory Microbiome on Host Responses to Respiratory Viral Infection. Vaccines. Nov 3 2017;5(4)doi:10.3390/vaccines5040040
  125. Barr T, Helms C, Grant K, Messaoudi I. Opposing effects of alcohol on the immune system. Progress in neuro-psychopharmacology & biological psychiatry. Feb 4 2016;65:242-51. doi:10.1016/j.pnpbp.2015.09.001
  126. Ouchi E, Niu K, Kobayashi Y, et al. Frequent alcohol drinking is associated with lower prevalence of self-reported common cold: a retrospective study. BMC Public Health. Nov 16 2012;12:987. doi:10.1186/1471-2458-12-987
  127. Takkouche B, Regueira-Méndez C, García-Closas R, Figueiras A, Gestal-Otero JJ, Hernán MA. Intake of wine, beer, and spirits and the risk of clinical common cold. American journal of epidemiology. May 1 2002;155(9):853-8. doi:10.1093/aje/155.9.853
  128. Cohen S, Tyrrell DA, Russell MA, Jarvis MJ, Smith AP. Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health. Sep 1993;83(9):1277-83. doi:10.2105/ajph.83.9.1277
  129. Golan R, Gepner Y, Shai I. Wine and Health-New Evidence. European journal of clinical nutrition. Jul 2019;72(Suppl 1):55-59. doi:10.1038/s41430-018-0309-5
  130. Costanzo S, de Gaetano G, Di Castelnuovo A, Djoussé L, Poli A, van Velden DP. Moderate alcohol consumption and lower total mortality risk: Justified doubts or established facts? Nutr Metab Cardiovasc Dis. Oct 2019;29(10):1003-1008. doi:10.1016/j.numecd.2019.05.062
  131. Araujo GV, Oliveira Junior MH, Peixoto DM, Sarinho ES. Probiotics for the treatment of upper and lower respiratory-tract infections in children: systematic review based on randomized clinical trials. Jornal de pediatria. Sep-Oct 2015;91(5):413-27. doi:10.1016/j.jped.2015.03.002
  132. Chan CKY, Tao J, Chan OS, Li HB, Pang H. Preventing Respiratory Tract Infections by Synbiotic Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. Jul 1 2020;11(4):979-988. doi:10.1093/advances/nmaa003
  133. Pregliasco F, Anselmi G, Fonte L, Giussani F, Schieppati S, Soletti L. A new chance of preventing winter diseases by the administration of synbiotic formulations. Journal of clinical gastroenterology. Sep 2008;42 Suppl 3 Pt 2:S224-33. doi:10.1097/MCG.0b013e31817e1c91
  134. Fonollá J, Gracián C, Maldonado-Lobón JA, et al. Effects of Lactobacillus coryniformis K8 CECT5711 on the immune response to influenza vaccination and the assessment of common respiratory symptoms in elderly subjects: a randomized controlled trial. European journal of nutrition. Feb 2019;58(1):83-90. doi:10.1007/s00394-017-1573-1
  135. Wang B, Hylwka T, Smieja M, Surrette M, Bowdish DME, Loeb M. Probiotics to Prevent Respiratory Infections in Nursing Homes: A Pilot Randomized Controlled Trial. J Am Geriatr Soc. Jul 2018;66(7):1346-1352. doi:10.1111/jgs.15396
  136. Turner RB, Woodfolk JA, Borish L, et al. Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial. Benef Microbes. Apr 26 2017;8(2):207-215. doi:10.3920/bm2016.0160
  137. Zhang H, Yeh C, Jin Z, et al. Prospective study of probiotic supplementation results in immune stimulation and improvement of upper respiratory infection rate. Synth Syst Biotechnol. Jun 2018;3(2):113-120. doi:10.1016/j.synbio.2018.03.001
  138. Shida K, Sato T, Iizuka R, et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European journal of nutrition. Feb 2017;56(1):45-53. doi:10.1007/s00394-015-1056-1
  139. Chong HX, Yusoff NAA, Hor YY, et al. Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study. J Dairy Sci. Jun 2019;102(6):4783-4797. doi:10.3168/jds.2018-16103
  140. Ciecierska A, Drywień ME, Hamulka J, Sadkowski T. Nutraceutical functions of beta-glucans in human nutrition. Roczniki Panstwowego Zakladu Higieny. 2019;70(4):315-324. doi:10.32394/rpzh.2019.0082
  141. Jesenak M, Urbancikova I, Banovcin P. Respiratory Tract Infections and the Role of Biologically Active Polysaccharides in Their Management and Prevention. Nutrients. Jul 20 2017;9(7)doi:10.3390/nu9070779
  142. Han B, Baruah K, Cox E, Vanrompay D, Bossier P. Structure-Functional Activity Relationship of β-Glucans From the Perspective of Immunomodulation: A Mini-Review. Front Immunol. 2020;11:658. doi:10.3389/fimmu.2020.00658
  143. Di Sotto A, Vitalone A, Di Giacomo S. Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview. Vaccines. Aug 22 2020;8(3)doi:10.3390/vaccines8030468
  144. Mah E, Kaden VN, Kelley KM, Liska DJ. Beverage Containing Dispersible Yeast β-Glucan Decreases Cold/Flu Symptomatic Days After Intense Exercise: A Randomized Controlled Trial. Journal of dietary supplements. 2020;17(2):200-210. doi:10.1080/19390211.2018.1495676
  145. Talbott SM, Talbott JA. Baker's yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women. J Am Coll Nutr. Aug 2012;31(4):295-300.
  146. Evans M, Falcone PH, Crowley DC, et al. Effect of a Euglena gracilis Fermentate on Immune Function in Healthy, Active Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. Dec 3 2019;11(12)doi:10.3390/nu11122926
  147. Dharsono T, Rudnicka K, Wilhelm M, Schoen C. Effects of Yeast (1,3)-(1,6)-Beta-Glucan on Severity of Upper Respiratory Tract Infections: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Subjects. J Am Coll Nutr. Jan 2019;38(1):40-50. doi:10.1080/07315724.2018.1478339
  148. Auinger A, Riede L, Bothe G, Busch R, Gruenwald J. Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body's defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects. European journal of nutrition. Dec 2013;52(8):1913-8. doi:10.1007/s00394-013-0492-z
  149. Jesenak M, Majtan J, Rennerova Z, Kyselovic J, Banovcin P, Hrubisko M. Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections. International immunopharmacology. Feb 2013;15(2):395-9. doi:10.1016/j.intimp.2012.11.020
  150. Dai X, Stanilka JM, Rowe CA, et al. Consuming Lentinula edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young Adults. Journal of the American College of Nutrition. 2015/11/02 2015;34(6):478-487. doi:10.1080/07315724.2014.950391
  151. Siddiqui M, Manansala JS, Abdulrahman HA, et al. Immune Modulatory Effects of Vitamin D on Viral Infections. Nutrients. Sep 21 2020;12(9)doi:10.3390/nu12092879
  152. Mathyssen C, Gayan-Ramirez G, Bouillon R, Janssens W. Vitamin D supplementation in respiratory diseases: evidence from randomized controlled trials. Pol Arch Intern Med. Nov 30 2017;127(11):775-784. doi:10.20452/pamw.4134
  153. Kühn J, Trotz P, Stangl GI. Prevalence of vitamin D insufficiency and evidence for disease prevention in the older population. Zeitschrift fur Gerontologie und Geriatrie. Jul 2018;51(5):567-572. Prävalenz für Vitamin-D-Insuffizienz und Evidenz für Krankheitsprävention bei der älteren Population. doi:10.1007/s00391-018-1390-z
  154. Shimizu Y, Ito Y, Yui K, Egawa K, Orimo H. Intake of 25-Hydroxyvitamin D3 Reduces Duration and Severity of Upper Respiratory Tract Infection: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study. The journal of nutrition, health & aging. 2018;22(4):491-500. doi:10.1007/s12603-017-0952-x
  155. Bergman P, Norlin AC, Hansen S, Björkhem-Bergman L. Vitamin D supplementation to patients with frequent respiratory tract infections: a post hoc analysis of a randomized and placebo-controlled trial. BMC research notes. Aug 30 2015;8:391. doi:10.1186/s13104-015-1378-3
  156. Loeb M, Dang AD, Thiem VD, et al. Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: A randomized controlled trial. Influenza Other Respir Viruses. Mar 2019;13(2):176-183. doi:10.1111/irv.12615
  157. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ (Clinical research ed). Feb 15 2017;356:i6583. doi:10.1136/bmj.i6583
  158. Ginde AA, Blatchford P, Breese K, et al. High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial. J Am Geriatr Soc. Mar 2017;65(3):496-503. doi:10.1111/jgs.14679
  159. Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The Role of Zinc in Antiviral Immunity. Adv Nutr. Jul 1 2019;10(4):696-710. doi:10.1093/advances/nmz013
  160. Wang MX, Win SS, Pang J. Zinc Supplementation Reduces Common Cold Duration among Healthy Adults: A Systematic Review of Randomized Controlled Trials with Micronutrients Supplementation. Am J Trop Med Hyg. Jul 2020;103(1):86-99. doi:10.4269/ajtmh.19-0718
  161. Hemilä H, Fitzgerald JT, Petrus EJ, Prasad A. Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients: An Individual Patient Data Meta-Analysis. Open forum infectious diseases. Spring 2017;4(2):ofx059. doi:10.1093/ofid/ofx059
  162. Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. Jun 18 2013;(6):Cd001364. doi:10.1002/14651858.CD001364.pub4
  163. Mossad SB. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. Qjm. Jan 2003;96(1):35-43. doi:10.1093/qjmed/hcg004
  164. Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial. Ear Nose Throat J. Oct 2000;79(10):778-80, 782.
  165. Belongia EA, Berg R, Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am J Med. Aug 2001;111(2):103-8. doi:10.1016/s0002-9343(01)00765-3
  166. Turner RB. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America . Dec 1 2001;33(11):1865-70. doi:10.1086/324347
  167. Eby GA, Halcomb WW. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial. Alternative therapies in health and medicine. Jan-Feb 2006;12(1):34-8.
  168. Veverka DV, Wilson C, Martinez MA, Wenger R, Tamosuinas A. Use of zinc supplements to reduce upper respiratory infections in United States Air Force Academy cadets. Complementary therapies in clinical practice . May 2009;15(2):91-5. doi:10.1016/j.ctcp.2009.02.006
  169. Allan GM, Arroll B. Prevention and treatment of the common cold: making sense of the evidence. Cmaj. Feb 18 2014;186(3):190-9. doi:10.1503/cmaj.121442
  170. Hemilä H. Vitamin C and Infections. Nutrients. Mar 29 2017;9(4)doi:10.3390/nu9040339
  171. Kim TK, Lim HR, Byun JS. Vitamin C supplementation reduces the odds of developing a common cold in Republic of Korea Army recruits: randomised controlled trial. BMJ Mil Health. Mar 5 2020;doi:10.1136/bmjmilitary-2019-001384
  172. Johnston CS, Barkyoumb GM, Schumacher SS. Vitamin C supplementation slightly improves physical activity levels and reduces cold incidence in men with marginal vitamin C status: a randomized controlled trial. Nutrients. Jul 9 2014;6(7):2572-83. doi:10.3390/nu6072572
  173. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. The Cochrane database of systematic reviews. Jan 2013;(1):CD000980. doi:10.1002/14651858.CD000980.pub4
  174. Ran L, Zhao W, Wang J, et al. Extra Dose of Vitamin C Based on a Daily Supplementation Shortens the Common Cold: A Meta-Analysis of 9 Randomized Controlled Trials. Biomed Res Int. 2018;2018:1837634. doi:10.1155/2018/1837634
  175. Vorilhon P, Arpajou B, Vaillant Roussel H, Merlin É, Pereira B, Cabaillot A. Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children. Eur J Clin Pharmacol. Mar 2019;75(3):303-311. doi:10.1007/s00228-018-2601-7
  176. Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral research. Aug 2009;83(2):165-70. doi:10.1016/j.antiviral.2009.04.009
  177. Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial. Evidence-based complementary and alternative medicine : eCAM. 2012;2012:841315. doi:10.1155/2012/841315
  178. Karsch-Völk M, Barrett B, Linde K. Echinacea for preventing and treating the common cold. Jama. Feb 10 2015;313(6):618-9. doi:10.1001/jama.2014.17145
  179. David S, Cunningham R. Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis. Complementary therapies in medicine. Jun 2019;44:18-26. doi:10.1016/j.ctim.2019.03.011
  180. Schapowal A, Klein P, Johnston SL. Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials. Adv Ther. Mar 2015;32(3):187-200. doi:10.1007/s12325-015-0194-4
  181. Careddu D, Pettenazzo A. Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children. International journal of general medicine. 2018;11:91-98. doi:10.2147/ijgm.S154198
  182. Michaelis M, Doerr HW, Cinatl J, Jr. Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. Mar 15 2011;18(5):384-6. doi:10.1016/j.phymed.2010.09.008
  183. Witte K, Koch E, Volk HD, Wolk K, Sabat R. The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes. PLoS One. 2015;10(9):e0138075. doi:10.1371/journal.pone.0138075
  184. Theisen LL, Muller CP. EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo. Antiviral research. May 2012;94(2):147-56. doi:10.1016/j.antiviral.2012.03.006
  185. Luna LA, Jr., Bachi AL, Novaes e Brito RR, et al. Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15. Phytomedicine. Feb 15 2011;18(4):303-8. doi:10.1016/j.phymed.2010.08.003
  186. Riley DS, Lizogub VG, Heger M, Funk P, Mueller H, Lehmacher W. Treatment with EPs 7630, a Pelargonium Sidoides Root Extract, Is Effective and Safe in Patients with the Common Cold: Results From a Randomized, Double Blind, Placebo-Controlled Clinical Trial. Integrative medicine (Encinitas, Calif). Feb 2019;18(1):42-51.
  187. Riley DS, Lizogub VG, Zimmermann A, Funk P, Lehmacher W. Efficacy and Tolerability of High-dose Pelargonium Extract in Patients With the Common Cold. Alternative therapies in health and medicine. Mar 2018;24(2):16-26.
  188. Schapowal A, Dobos G, Cramer H, et al. Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis. Heliyon. Nov 2019;5(11):e02904. doi:10.1016/j.heliyon.2019.e02904
  189. Seifert G, Brandes-Schramm J, Zimmermann A, Lehmacher W, Kamin W. Faster recovery and reduced paracetamol use - a meta-analysis of EPs 7630 in children with acute respiratory tract infections. BMC Pediatr. Apr 23 2019;19(1):119. doi:10.1186/s12887-019-1473-z
  190. Kamin W, Funk P, Seifert G, Zimmermann A, Lehmacher W. EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited. Current medical research and opinion. Mar 2018;34(3):475-485. doi:10.1080/03007995.2017.1402754
  191. Hossain MS, Urbi Z, Sule A, Hafizur Rahman KM. Andrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology. TheScientificWorldJournal. 2014;2014:274905. doi:10.1155/2014/274905
  192. Hu XY, Wu RH, Logue M, et al. Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis. PLoS One. 2017;12(8):e0181780. doi:10.1371/journal.pone.0181780
  193. Jayakumar T, Hsieh CY, Lee JJ, Sheu JR. Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide. Evidence-based complementary and alternative medicine : eCAM. 2013;2013:846740. doi:10.1155/2013/846740
  194. Suriyo T, Pholphana N, Ungtrakul T, et al. Clinical Parameters following Multiple Oral Dose Administration of a Standardized Andrographis paniculata Capsule in Healthy Thai Subjects. Planta Med. Jun 2017;83(9):778-789. doi:10.1055/s-0043-104382
  195. Saxena RC, Singh R, Kumar P, et al. A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection. Phytomedicine. Mar 2010;17(3-4):178-85. doi:10.1016/j.phymed.2009.12.001
  196. Gabrielian ES, Shukarian AK, Goukasova GI, et al. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine. Oct 2002;9(7):589-97. doi:10.1078/094471102321616391
  197. Wagner L, Cramer H, Klose P, et al. Herbal Medicine for Cough: a Systematic Review and Meta-Analysis. Forschende Komplementarmedizin (2006). 2015;22(6):359-68. doi:10.1159/000442111
  198. Iqbal H, Rhee DK. Ginseng alleviates microbial infections of the respiratory tract: a review. J Ginseng Res. Mar 2020;44(2):194-204. doi:10.1016/j.jgr.2019.12.001
  199. Lee JS, Hwang HS, Ko EJ, et al. Immunomodulatory activity of red ginseng against influenza A virus infection. Nutrients. Jan 27 2014;6(2):517-29. doi:10.3390/nu6020517
  200. Predy GN, Goel V, Lovlin R, Donner A, Stitt L, Basu TK. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. Cmaj. Oct 25 2005;173(9):1043-8. doi:10.1503/cmaj.1041470
  201. McElhaney JE, Goel V, Toane B, Hooten J, Shan JJ. Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial. Journal of alternative and complementary medicine (New York, NY). Mar 2006;12(2):153-7. doi:10.1089/acm.2006.12.153
  202. McElhaney JE, Gravenstein S, Cole SK, et al. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J Am Geriatr Soc. Jan 2004;52(1):13-9. doi:10.1111/j.1532-5415.2004.52004.x
  203. Vohra S, Johnston BC, Laycock KL, et al. Safety and tolerability of North American ginseng extract in the treatment of pediatric upper respiratory tract infection: a phase II randomized, controlled trial of 2 dosing schedules. Pediatrics. Aug 2008;122(2):e402-10. doi:10.1542/peds.2007-2186
  204. High KP, Case D, Hurd D, et al. A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia. J Support Oncol. Sep-Oct 2012;10(5):195-201. doi:10.1016/j.suponc.2011.10.005
  205. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs under experimental and clinical research. 1996;22(2):65-72.
  206. Kaneko H, Nakanishi K. Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, korean red ginseng: specifically, its anti-stress action for prevention of disease. Journal of pharmacological sciences. Jun 2004;95(2):158-62. doi:10.1254/jphs.fmj04001x5
  207. Sen S, Mansell TJ. Yeasts as probiotics: Mechanisms, outcomes, and future potential. Fungal Genetics and Biology. 2020/04/01/ 2020;137:103333. doi:
  208. Moyad MA, Robinson LE, Zawada ET, et al. Immunogenic yeast-based fermentate for cold/flu-like symptoms in nonvaccinated individuals. Journal of alternative and complementary medicine (New York, NY). 2010;16(2):213-218. doi:10.1089/acm.2009.0310
  209. Moyad MA, Robinson LE, Zawada ET, Jr., et al. Effects of a modified yeast supplement on cold/flu symptoms. Urologic nursing. Feb 2008;28(1):50-5.
  210. Ried K. Garlic Lowers Blood Pressure in Hypertensive Individuals, Regulates Serum Cholesterol, and Stimulates Immunity: An Updated Meta-analysis and Review. J Nutr. Feb 2016;146(2):389s-396s. doi:10.3945/jn.114.202192
  211. Rouf R, Uddin SJ, Sarker DK, et al. Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data. Trends in food science &amp; technology. 2020/10// 2020;104:219-234. doi:10.1016/j.tifs.2020.08.006
  212. Percival SS. Aged Garlic Extract Modifies Human Immunity. J Nutr. Feb 2016;146(2):433s-436s. doi:10.3945/jn.115.210427
  213. Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Adv Ther. Jul-Aug 2001;18(4):189-93.
  214. Andrianova IV, Sobenin IA, Sereda EV, Borodina LI, Studenikin MI. [Effect of long-acting garlic tablets "allicor" on the incidence of acute respiratory viral infections in children]. Terapevticheskii arkhiv . 2003;75(3):53-6. Vliianie chesnochnykh tabletok prolongirovannogo deĭstviia "allikor" na zabolevaemost' ostrymi respiratornymivirusnymi infektsiiami u deteĭ.
  215. Kanwal A, Ahmad M, Aslam S, Naqvi SAR, Saif MJ. Recent Advances in Antiviral Benzimidazole Derivatives: A Mini Review. Pharmaceutical Chemistry Journal. 2019/06/01 2019;53(3):179-187. doi:10.1007/s11094-019-01976-3
  216. Furushima D, Ide K, Yamada H. Effect of Tea Catechins on Influenza Infection and the Common Cold with a Focus on Epidemiological/Clinical Studies. Molecules (Basel, Switzerland). Jul 20 2018;23(7)doi:10.3390/molecules23071795
  217. Rowe CA, Nantz MP, Bukowski JF, Percival SS. Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gamma,delta T cell function: a randomized, double-blind, placebo-controlled study. J Am Coll Nutr. Oct 2007;26(5):445-52. doi:10.1080/07315724.2007.10719634
  218. Furushima D, Nishimura T, Takuma N, et al. Prevention of Acute Upper Respiratory Infections by Consumption of Catechins in Healthcare Workers: A Randomized, Placebo-Controlled Trial. Nutrients. Dec 18 2019;12(1)doi:10.3390/nu12010004
  219. Matsumoto K, Yamada H, Takuma N, Niino H, Sagesaka YM. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. BMC Complement Altern Med. 2011;11:15. doi:10.1186/1472-6882-11-15
  220. Park M, Yamada H, Matsushita K, et al. Green tea consumption is inversely associated with the incidence of influenza infection among schoolchildren in a tea plantation area of Japan. J Nutr. Oct 2011;141(10):1862-70. doi:10.3945/jn.110.137547
  221. Porter RS, Bode RF. A Review of the Antiviral Properties of Black Elder (Sambucus nigra L.) Products. Phytother Res. Apr 2017;31(4):533-554. doi:10.1002/ptr.5782
  222. Krawitz C, Mraheil MA, Stein M, et al. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med. Feb 25 2011;11:16. doi:10.1186/1472-6882-11-16
  223. Roschek B, Jr., Fink RC, McMichael MD, Li D, Alberte RS. Elderberry flavonoids bind to and prevent H1N1 infection in vitro. Phytochemistry. Jul 2009;70(10):1255-61. doi:10.1016/j.phytochem.2009.06.003
  224. Tiralongo E, Wee SS, Lea RA. Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. Nutrients. Mar 24 2016;8(4):182. doi:10.3390/nu8040182
  225. Harnett J, Oakes K, Carè J, et al. The effects of Sambucus nigra berry on acute respiratory viral infections: a rapid review of clinical studies. Adv Integr Med. Aug 22 2020;doi:10.1016/j.aimed.2020.08.001
  226. Hawkins J, Baker C, Cherry L, Dunne E. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. Complement Ther Med. Feb 2019;42:361-365. doi:10.1016/j.ctim.2018.12.004
  227. Macknin M, Wolski K, Negrey J, Mace S. Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial. J Gen Intern Med. Sep 14 2020;doi:10.1007/s11606-020-06170-w
  228. Choi JY, Paik DJ, Kwon DY, Park Y. Dietary supplementation with rice bran fermented with Lentinus edodes increases interferon-γ activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study. Nutr J. Apr 22 2014;13:35. doi:10.1186/1475-2891-13-35
  229. Maeda H, Ichihashi K, Fujii T, et al. Oral administration of hydrolyzed rice bran prevents the common cold syndrome in the elderly based on its immunomodulatory action. BioFactors (Oxford, England). 2004;21(1-4):185-7.
  230. Jefferson A, Adolphus K. The Effects of Intact Cereal Grain Fibers, Including Wheat Bran on the Gut Microbiota Composition of Healthy Adults: A Systematic Review. Frontiers in nutrition. 2019;6:33. doi:10.3389/fnut.2019.00033
  231. Mendis M, Leclerc E, Simsek S. Arabinoxylans, gut microbiota and immunity. Carbohydrate polymers. Mar 30 2016;139:159-66. doi:10.1016/j.carbpol.2015.11.068
  232. Tiwari UP, Fleming SA, Abdul Rasheed MS, Jha R, Dilger RN. The role of oligosaccharides and polysaccharides of xylan and mannan in gut health of monogastric animals. Journal of nutritional science. 2020;9:e21. doi:10.1017/jns.2020.14
  233. Elsaid AF, Shaheen M, Ghoneum M. Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double-blind, placebo-controlled clinical trial. Exp Ther Med. Mar 2018;15(3):2313-2320. doi:10.3892/etm.2018.5713
  234. Erkekoğlu P, Aşçı A, Ceyhan M, et al. Selenium levels, selenoenzyme activities and oxidant/antioxidant parameters in H1N1-infected children. The Turkish journal of pediatrics. May-Jun 2013;55(3):271-82.
  235. Louria DB. Undernutrition can affect the invading microorganism. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America . Aug 15 2007;45(4):470-4. doi:10.1086/520026
  236. Jaspers I, Zhang W, Brighton LE, Carson JL, Styblo M, Beck MA. Selenium deficiency alters epithelial cell morphology and responses to influenza. Free radical biology & medicine. Jun 15 2007;42(12):1826-37. doi:10.1016/j.freeradbiomed.2007.03.017
  237. Schmidt K, Zirkler S. [Dietary efficacy of a micronutrient combination in patients with recurrent upper respiratory tract infections. Results of a placebo-controlled doubleblind study.]. MMW Fortschr Med. Oct 2011;153(Suppl 3):83-89. Diätetische Wirksamkeit einer Mikronährstoffkombination bei rezidivierenden Atemwegsinfekten : Ergebnisse einer placebokontrollierten Doppelblindstudie. doi:10.1007/s15006-011-1630-2
  238. Isbaniah F, Wiyono WH, Yunus F, Setiawati A, Totzke U, Verbruggen MA. Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial. J Clin Pharm Ther. Oct 2011;36(5):568-76. doi:10.1111/j.1365-2710.2010.01212.x
  239. Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life. Apr 2019;71(4):487-494. doi:10.1002/iub.1976
  240. Wu D, Meydani SN. Age-associated changes in immune function: impact of vitamin E intervention and the underlying mechanisms. Endocr Metab Immune Disord Drug Targets. 2014;14(4):283-9.
  241. Zhang J, Sun RR, Yan ZX, Yi WX, Yue B. Correlation of serum vitamin A, D, and E with recurrent respiratory infection in children. European review for medical and pharmacological sciences. Sep 2019;23(18):8133-8138. doi:10.26355/eurrev_201909_19033
  242. Zhang X, Ding F, Li H, et al. Low Serum Levels of Vitamins A, D, and E Are Associated with Recurrent Respiratory Tract Infections in Children Living in Northern China: A Case Control Study. PLoS One. 2016;11(12):e0167689. doi:10.1371/journal.pone.0167689
  243. Qi YJ, Niu QL, Zhu XL, Zhao XZ, Yang WW, Wang XJ. Relationship between deficiencies in vitamin A and E and occurrence of infectious diseases among children. European review for medical and pharmacological sciences . Dec 2016;20(23):5009-5012.
  244. Raposo SE, Fondell E, Ström P, et al. Intake of vitamin C, vitamin E, selenium, zinc and polyunsaturated fatty acids and upper respiratory tract infection-a prospective cohort study. European journal of clinical nutrition. Apr 2017;71(4):450-457. doi:10.1038/ejcn.2016.261
  245. Hemilä H, Virtamo J, Albanes D, Kaprio J. The effect of vitamin E on common cold incidence is modified by age, smoking and residential neighborhood. J Am Coll Nutr. Aug 2006;25(4):332-9. doi:10.1080/07315724.2006.10719543
  246. De la Fuente M, Hernanz A, Guayerbas N, Victor VM, Arnalich F. Vitamin E ingestion improves several immune functions in elderly men and women. Free Radic Res. Mar 2008;42(3):272-80. doi:10.1080/10715760801898838
  247. Meydani SN, Leka LS, Fine BC, et al. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. Jama. Aug 18 2004;292(7):828-36. doi:10.1001/jama.292.7.828
  248. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. Jama. Aug 14 2002;288(6):715-21. doi:10.1001/jama.288.6.715
  249. Kell DB, Heyden EL, Pretorius E. The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Front Immunol. 2020;11:1221. doi:10.3389/fimmu.2020.01221
  250. Vitetta L, Coulson S, Beck SL, Gramotnev H, Du S, Lewis S. The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study. Complementary therapies in medicine. Jun 2013;21(3):164-71. doi:10.1016/j.ctim.2012.12.006
  251. Oda HN, M.; Wakabayashi, H.; Yamauchi, K.;Toida, T.; Iwatsuki, K.; et al. Questionnaire survey on the subjective effects of a lactoferrin supplement. J Jpn Soc Complement Altern Med. 2012;2012(9):121–8.
  252. Kurihara S, Shibakusa T, Tanaka KA. Cystine and theanine: amino acids as oral immunomodulative nutrients. Springerplus. Nov 26 2013;2:635. doi:10.1186/2193-1801-2-635
  253. Kurihara S, Hiraoka T, Akutsu M, Sukegawa E, Bannai M, Shibahara S. Effects of (L)-cystine and (L)-theanine supplementation on the common cold: a randomized, double-blind, and placebo-controlled trial. Journal of amino acids. 2010;2010:307475. doi:10.4061/2010/307475
  254. Murakami S, Kurihara S, Titchenal CA, Ohtani M. Suppression of exercise-induced neutrophilia and lymphopenia in athletes by cystine/theanine intake: a randomized, double-blind, placebo-controlled trial. Journal of the International Society of Sports Nutrition. Jun 4 2010;7(1):23. doi:10.1186/1550-2783-7-23
  255. Murakami S, Kurihara S, Koikawa N, et al. Effects of oral supplementation with cystine and theanine on the immune function of athletes in endurance exercise: randomized, double-blind, placebo-controlled trial. Bioscience, biotechnology, and biochemistry. Apr 23 2009;73(4):817-21. doi:10.1271/bbb.80663
  256. Kawada S, Kobayashi K, Ohtani M, Fukusaki C. Cystine and theanine supplementation restores high-intensity resistance exercise-induced attenuation of natural killer cell activity in well-trained men. Journal of strength and conditioning research / National Strength & Conditioning Association . Mar 2010;24(3):846-51. doi:10.1519/JSC.0b013e3181c7c299
  257. Li Y, Yao J, Han C, et al. Quercetin, Inflammation and Immunity. Nutrients. Mar 15 2016;8(3):167. doi:10.3390/nu8030167
  258. Mlcek J, Jurikova T, Skrovankova S, Sochor J. Quercetin and Its Anti-Allergic Immune Response. Molecules. May 12 2016;21(5)doi:10.3390/molecules21050623
  259. Heinz SA, Henson DA, Austin MD, Jin F, Nieman DC. Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacol Res. Sep 2010;62(3):237-42. doi:10.1016/j.phrs.2010.05.001
  260. Nieman DC, Henson DA, Gross SJ, et al. Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc. Sep 2007;39(9):1561-9. doi:10.1249/mss.0b013e318076b566
  261. Imai Y. Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection. Biochim Biophys Acta. Apr 2015;1851(4):496-502. doi:10.1016/j.bbalip.2015.01.006
  262. Rutting S, Zakarya R, Bozier J, et al. Dietary Fatty Acids Amplify Inflammatory Responses to Infection through p38 MAPK Signaling. American journal of respiratory cell and molecular biology. May 2019;60(5):554-568. doi:10.1165/rcmb.2018-0215OC
  263. Hageman JH, Hooyenga P, Diersen-Schade DA, Scalabrin DM, Wichers HJ, Birch EE. The impact of dietary long-chain polyunsaturated fatty acids on respiratory illness in infants and children. Current allergy and asthma reports. Dec 2012;12(6):564-73. doi:10.1007/s11882-012-0304-1
  264. Linday LA. Cod liver oil, young children, and upper respiratory tract infections. J Am Coll Nutr. Dec 2010;29(6):559-62. doi:10.1080/07315724.2010.10719894
  265. Sirisinha S. The pleiotropic role of vitamin A in regulating mucosal immunity. Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand . Jun 2015;33(2):71-89.
  266. Imdad A, Mayo-Wilson E, Herzer K, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. The Cochrane database of systematic reviews. Mar 11 2017;3(3):Cd008524. doi:10.1002/14651858.CD008524.pub3
  267. Brown N, Roberts C. Vitamin A for acute respiratory infection in developing countries: a meta-analysis. Acta Paediatr. Nov 2004;93(11):1437-42. doi:10.1080/08035250410022143
  268. Fu Z, Fan X, Wang X, Gao X. Cistanches Herba: An overview of its chemistry, pharmacology, and pharmacokinetics property. Journal of ethnopharmacology. Jun 12 2018;219:233-247. doi:10.1016/j.jep.2017.10.015
  269. Li Z, Lin H, Gu L, Gao J, Tzeng CM. Herba Cistanche (Rou Cong-Rong): One of the Best Pharmaceutical Gifts of Traditional Chinese Medicine. Frontiers in pharmacology. 2016;7:41. doi:10.3389/fphar.2016.00041
  270. Yonei Y, Kitano T, Ogura M, et al. Effects of Health Food Containing Cistanche Deserticola Extract on QOL and Safety in Elderly: An Open Pilot Study of 12-week Oral Treatment. Anti-aging Medicine. 2011;8:7-14.
  271. NaveenKumar SK, Hemshekhar M, Jagadish S, et al. Melatonin restores neutrophil functions and prevents apoptosis amid dysfunctional glutathione redox system. Journal of pineal research. Oct 2020;69(3):e12676. doi:10.1111/jpi.12676
  272. Chen Z, Liu L, Gao C, et al. Astragali Radix (Huangqi): A promising edible immunomodulatory herbal medicine. Journal of ethnopharmacology. Aug 10 2020;258:112895. doi:10.1016/j.jep.2020.112895
  273. Liu P, Zhao H, Luo Y. Anti-Aging Implications of Astragalus Membranaceus (Huangqi): A Well-Known Chinese Tonic. Aging Dis. Dec 2017;8(6):868-886. doi:10.14336/ad.2017.0816
  274. Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. A Review of the Pharmacological Action of Astragalus Polysaccharide. Frontiers in pharmacology. 2020;11:349. doi:10.3389/fphar.2020.00349
  275. Zhang J, Wu C, Gao L, Du G, Qin X. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects. Advances in pharmacology (San Diego, Calif). 2020;87:89-112. doi:10.1016/bs.apha.2019.08.002
  276. Harley CB, Liu W, Blasco M, et al. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res. Feb 2011;14(1):45-56. doi:10.1089/rej.2010.1085
  277. Cör D, Knez Ž, Knez Hrnčič M. Antitumour, Antimicrobial, Antioxidant and Antiacetylcholinesterase Effect of Ganoderma Lucidum Terpenoids and Polysaccharides: A Review. Molecules (Basel, Switzerland). Mar 13 2018;23(3)doi:10.3390/molecules23030649
  278. Wang X, Lin Z. Immunomodulating Effect of Ganoderma (Lingzhi) and Possible Mechanism. Adv Exp Med Biol. 2019;1182:1-37. doi:10.1007/978-981-32-9421-9_1
  279. Avtonomova AV, Krasnopolskaya LM. [Antiviral properties of basidiomycetes metabolites]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] / Ministerstvo meditsinskoi i mikrobiologicheskoi promyshlennosti SSSR . 2014;59(7-8):41-8.
  280. Baradaran Rahimi V, Ghadiri M, Ramezani M, Askari VR. Antiinflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: Evidence from cellular, animal, and clinical studies. Phytother Res. Apr 2020;34(4):685-720. doi:10.1002/ptr.6565
  281. Park SW, Kwon MJ, Yoo JY, Choi HJ, Ahn YJ. Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses. BMC Complement Altern Med. May 26 2014;14:171. doi:10.1186/1472-6882-14-171
  282. Acquadro S, Civra A, Cagliero C, et al. Punica granatum Leaf Ethanolic Extract and Ellagic Acid as Inhibitors of Zika Virus Infection. Planta Med. Dec 2020;86(18):1363-1374. doi:10.1055/a-1232-5705
  283. Haidari M, Ali M, Ward Casscells S, 3rd, Madjid M. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine. Dec 2009;16(12):1127-36. doi:10.1016/j.phymed.2009.06.002
  284. Lim SK, Othman R, Yusof R, Heh CH. Rational drug discovery: Ellagic acid as a potent dual-target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes. Chem Biol Drug Des. Jan 2021;97(1):28-40. doi:10.1111/cbdd.13756
  285. Prall SP, Muehlenbein MP. DHEA Modulates Immune Function: A Review of Evidence. Vitam Horm. 2018;108:125-144. doi:10.1016/bs.vh.2018.01.023
  286. Bauer ME, Muller GC, Correa BL, Vianna P, Turner JE, Bosch JA. Psychoneuroendocrine interventions aimed at attenuating immunosenescence: a review. Biogerontology. Feb 2013;14(1):9-20. doi:10.1007/s10522-012-9412-5
  287. Racchi M, Buoso E, Ronfani M, et al. Role of Hormones in the Regulation of RACK1 Expression as a Signaling Checkpoint in Immunosenescence. International journal of molecular sciences. Jul 6 2017;18(7)doi:10.3390/ijms18071453
  288. Rutkowski K, Sowa P, Rutkowska-Talipska J, Kuryliszyn-Moskal A, Rutkowski R. Dehydroepiandrosterone (DHEA): hypes and hopes. Drugs. Jul 2014;74(11):1195-207. doi:10.1007/s40265-014-0259-8
  289. Yang Q, Mao Q, Liu M, et al. The inhibitory effect of dehydroepiandrosterone and its derivatives against influenza A virus in vitro and in vivo. Arch Virol. Nov 2016;161(11):3061-72. doi:10.1007/s00705-016-2993-6
  290. Loria RMB-N, D. Protective Effects of DHEA and AED against Viral, Bacterial and Parasitic Infections. Israel Journal of Veterinary Medicine. 2011;66(4):119–129.
  291. Loria RM. Beta-androstenes and resistance to viral and bacterial infections. Neuroimmunomodulation. 2009;16(2):88-95. doi:10.1159/000180263
  292. Padgett DA, Loria RM, Sheridan JF. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J Neuroimmunol. Sep 1997;78(1-2):203-11. doi:10.1016/s0165-5728(97)00102-1
  293. Beishuizen A, Thijs LG, Vermes I. Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit Care. Oct 2002;6(5):434-8. doi:10.1186/cc1530
  294. Bentley C, Hazeldine J, Greig C, Lord J, Foster M. Dehydroepiandrosterone: a potential therapeutic agent in the treatment and rehabilitation of the traumatically injured patient. Burns & trauma. 2019;7:26. doi:10.1186/s41038-019-0158-z
  295. Balderrama-Carmona AP, Silva-Beltrán NP, Gálvez-Ruiz J-C, Ruíz-Cruz S, Chaidez-Quiroz C, Morán-Palacio EF. Antiviral, Antioxidant, and Antihemolytic Effect of Annona muricata L. Leaves Extracts. Plants (Basel). 2020;9(12):1650. doi:10.3390/plants9121650
  296. Wahab N, Ibrahim N, Kamarudin M, et al. Cytotoxicity and antiviral activity of Annona muricata aqueous leaves extract against dengue virus type 2. J Fundamental Appl Sci. 2018;10(1S)
  297. Turner RB, Fowler SL, Berg K. Treatment of the common cold with troxerutin. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica . Sep 2004;112(9):605-11. doi:10.1111/j.1600-0463.2004.apm1120908.x
  298. Reiter R, Ma Q, Sharma R. Treatment of ebola and other infectious diseases: melatonin “goes viral”. Melatonin Research. 2020;3:43-57.
  299. Lee HK, Hwang IH, Kim SY, Pyo SY. The effect of exercise on prevention of the common cold: a meta-analysis of randomized controlled trial studies. Korean journal of family medicine. May 2014;35(3):119-26. doi:10.4082/kjfm.2014.35.3.119
  300. Prather AA, Janicki-Deverts D, Hall MH, Cohen S. Behaviorally Assessed Sleep and Susceptibility to the Common Cold. Sleep. Sep 1 2015;38(9):1353-9. doi:10.5665/sleep.4968
  301. Takkouche B, Regueira C, Gestal-Otero JJ. A cohort study of stress and the common cold. Epidemiology (Cambridge, Mass). May 2001;12(3):345-9. doi:10.1097/00001648-200105000-00015
  302. Heinz SA, Henson DA, Austin MD, Jin F, Nieman DC. Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacological research : the official journal of the Italian Pharmacological Society. Sep 2010;62(3):237-42. doi:10.1016/j.phrs.2010.05.001